%PDF-1.2 % 2 0 obj << /Length 18097 >> stream 0 g /GS2 gs 1 i 58.28 728.957 83.395 -0.85 re f* BT /F1 1 Tf 11.955 0 0 11.955 58.28 730.828 Tm 0.0213 Tc [(PER)4.4(S)-0.5(PECTIVE)]TJ /F2 1 Tf 14.944 0 0 14.944 58.28 697.946 Tm 0.021 Tc [(Do)-226.2(long-acting)]TJ /F3 1 Tf 7.4584 0 TD 0 Tc 0 Tw (b)Tj /F2 1 Tf 11.208 0 0 9.962 178.299 695.452 Tm (2)Tj 14.944 0 0 14.944 184.819 697.946 Tm 0.0208 Tc [(-adrenergic)-227.7(a)0(gonists)-227.7(d)1.3(eserve)-227.7(a)-223.9(d)-2.5(ifferent)-226.6(place)-223.9(i)-1.7(n)]TJ -5.0684 -1.0357 TD 0.021 Tc [(guidelines)-329.9(f)-2.6(or)-333.8(the)-333.7(t)1.2(reatment)-332.7(of)-332.7(asthma)-329.9(a)0.2(nd)-332.4(COPD?)]TJ /F4 1 Tf 10.959 0 0 10.959 253.644 645.108 Tm 0 Tc [(C.P.)-335.4(van)-330.8(Schayck)]TJ /F5 1 Tf 9.963 0 0 9.963 68.258 605.764 Tm -0.018 Tc [(T)-18(h)-0.9(e)-383.4(i)-18(nt)-18(ro)-18(du)-18(ct)-18(io)-18(n)-372.3(o)-18(f)-373.9(l)-18(on)-18(g-)-18(ac)-18(ti)-18(ng)]TJ /F3 1 Tf 12.9517 0 TD 0 Tc (b)Tj /F5 1 Tf 7.472 0 0 6.641 202.734 604.12 Tm (2)Tj 9.963 0 0 9.963 206.362 605.764 Tm [(-a)19.2(dr)13.9(en)20.8(er)24.9(gi)18.9(c)-365.4(a)0(g)20.8(o)0(n)15.5(i)0(s)17.7(t)0(s)]TJ -14.8637 -1.0584 TD [(\(s)18.4(al)18.4(me)12(te)18.4(ro)19.6(l)-356(a)0(n)20.8(d)-353.6(fo)19.6(rm)16.5(ot)13.2(er)19.2(ol)18.9(\))-355.2(i)0(n)-345.3(t)13.9(he)-349.1(ea)20.4(rl)17.3(y)-353.6(1)0(9)21.2(9)0(0)15.5(s)-354.8(ca)20.4(me)-346.5(at)-345.7(a)]TJ T* [(ra)19.2(th)13.2(er)-174.2(cr)13.5(it)16.5(i)13.9(c)0(a)14.7(l)-185.2(mo)12.4(me)17.7(nt)18.9(.)-188.2(V)114.8(ar)19.2(io)13.2(us)-173.4(ep)15.1(id)18.9(em)17.7(io)13.2(lo)18.9(gi)18.9(ca)14.7(l)-185.2(s)0(t)17.7(u)0(d)21.2(i)0(e)12.8(s)-184.1(ha)15.1(d)]TJ 0 -1.0527 TD [(re)19.2(ce)14.7(nt)18.9(ly)-151.9(de)20.8(mo)18.1(ns)14.4(tr)17.3(at)18.4(ed)-149.9(a)-154.8(r)0(e)19.2(l)0(a)12.8(t)0(i)16.5(o)0(n)21.2(s)0(h)20(i)0(p)-151.9(b)0(e)20.8(t)0(w)14.9(e)0(e)14.7(n)-154.4(pr)19.6(ol)13.2(on)21.2(ge)15.1(d)-154.4(u)0(s)14.4(e)]TJ 0 -1.0584 TD (of)Tj /F3 1 Tf 0.9674 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 73.304 561.94 Tm (2)Tj 9.963 0 0 9.963 76.989 563.641 Tm [(-a)19.2(dr)19.6(en)15.1(er)30.6(gi)13.2(c)-154.8(a)0(g)20.8(o)0(n)15.5(i)0(s)17.7(t)0(s)-141.7(a)0(n)15.1(d)-154.4(mo)18.1(rt)17.3(al)18.4(it)16.5(y)-154.4(d)0(u)15.5(e)-149.1(to)-146.2(as)13.9(t)13.9(h)0(m)12.4(a)-154.8([1)19.6(\2615].)]TJ -1.8779 -1.0584 TD [(These)-385.5(publi)-8.6(cations)-387.7(did)-380.2(not)-380.2(g)-6.5(o)-376.3(unheeded)-13(:)-378.7(they)-381.4(tri)-8.6(ggered)]TJ T* [(intense)-245.4(debate)-241.5(on)-240.5(the)-238.4(possi)-8.6(ble)-238.4(risk)-8.2(s)-235.3(o)0(f)-236.4(the)-244.1(use)-237.2(of)]TJ /F3 1 Tf 19.2853 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 255.912 540.907 Tm (2)Tj 9.963 0 0 9.963 259.653 542.551 Tm (-agon-)Tj -20.2128 -1.0584 TD [(ists.)-289.4(One)-285.5(of)-287.7(the)-289.6(main)-287.8(critici)-11.6(sms)-286.7(that)-287.1(these)-292.7(studies)-291.7(elicited)]TJ T* [(was)-423.2(that)-417.9(they)-421.3(did)-420.1(not)-420.1(provide)-419.4(a)-6.9(n)0(y)-416.9(hard)-420.5(eviden)-7.8(ce)-417.7(for)-420.9(a)]TJ T* [(cause/)-9.4(effect)-153.6(relations)-11.9(hip.)-158.7(In)-156.8(other)-161.8(wor)-7.8(ds,)-156.7(it)-159.9(could)-160.2(not)-158.3(be)-161.3(de-)]TJ T* [(duced)-198.1(from)-197.2(these)-196(studies)-200.7(that)-196(prolo)-7.8(nged)-191.2(use)-197.4(of)]TJ /F3 1 Tf 18.2894 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 246.047 498.727 Tm (2)Tj 9.963 0 0 9.963 249.789 500.372 Tm (-agonists)Tj -19.2227 -1.0584 TD [(\(fenot)-10.6(erol)-377.3(in)-373.8(particula)-11.1(r\))-374.6(was)-377.7(the)-375(true)-377.3(cause)-381.8(of)-373(incre)-8.6(ased)]TJ 0 -1.0528 TD [(mortali)-11.9(ty)-191.7(due)-190.5(to)-191.7(asthma.)-194.6(Sev)-7.6(ere)-192.5(asthma)-194.2(is)-192.9(accom)-8.2(panied)-195.6(by)]TJ 0 -1.0584 TD [(not)-198.1(only)-198.9(higher)-202.4(mort)-10.2(ality)-199.2(but)-198.1(also)-200.5(freque)-8.6(nt)-197.4(use)-197.4(of)]TJ /F3 1 Tf 19.2853 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 255.912 467.093 Tm (2)Tj 9.963 0 0 9.963 259.653 468.794 Tm (-agon-)Tj -20.2128 -1.0584 TD [(ists.)-175.6(The)-171.8(connection)-178.6(between)-177.9(prescript)-11.1(ion)-169.7(of)-168.1(these)-173.2(ag)-7.6(onists)]TJ T* [(and)-315.7(mortali)-11.9(ty)-311.2(could)-319.6(there)-8.6(fore)-313.9(also)-320(be)-314.9(revers)-9.8(ed)-314.9(\(so-calle)-11.5(d)]TJ T* [("conf)-8.8(ounding)-332.1(by)-331.6(indi)-7.8(cation"\))-10.5(.)-330.4(A)-329.1(met)-8.2(a-analysis)-341.9(based)-335.9(on)]TJ T* [(the)-232.7(most)-237.4(imp)-7.8(ortant)-233.3(epidem)-10.9(iological)-239.1(studi)-9.8(es)-230.7(confi)-8.2(rmed)-235.8(the)]TJ T* [(suspic)-9.7(ion)-312(that)-309.8(there)-321.6(indeed)-315.1(existed)-319.4(a)-308.5(revers)-9.8(e)-308.5(relations)-11.9(hip)]TJ T* [([6].)-199.3(However)18.5(,)-193.9(a)0(s)-202.3(meta-anal)-12.3(ysis)-201.3(of)-196.6(such)-203.8(patient/contr)-13.2(ol)-197.4(stu-)]TJ 0 -1.0528 TD [(dies)-314.3(always)-320.2(has)-311.2(a)-308.5(numbe)-7.4(r)-309.7(o)0(f)-316.1(methodol)-8.7(ogical)-317.4(limitati)-12.6(ons,)]TJ 0 -1.0584 TD [(there)-213.5(was)-207(a)-211.7(clear)-208.2(need)-214.4(for)-204.6(random)-9.7(ized)-211.1(prospe)-7.8(ctive)-208.6(studi)-9.8(es.)]TJ 1.0015 -1.0527 TD [(In)-213.7(19)15.5(90)21.2(/1)18.9(99)15.5(1,)-211.7(tw)14.9(o)-222.7(r)0(a)19.2(n)0(d)21.2(o)0(m)12.4(i)0(z)18.4(e)0(d)-212.5(l)0(o)18.9(n)0(g)15.5(i)0(t)16.5(u)0(d)21.2(i)0(n)18.9(a)0(l)-214.9(i)0(n)18.9(t)0(e)12.8(r)0(v)19.6(e)0(n)15.1(t)13.9(io)13.2(n)]TJ -1.0015 -1.0584 TD [(st)17.7(ud)15.5(ie)18.4(s)-189.7(w)12.4(er)13.5(e)-189(p)0(u)21.2(b)0(l)13.2(i)0(s)17.7(h)0(e)20.8(d)0(,)-177.6(i)0(n)-180.3(w)0(h)17.3(i)0(c)12.8(h)-188.6(pr)19.6(ol)18.9(on)15.5(ge)20.8(d)-188.6(u)0(s)14.4(e)-189(of)]TJ /F3 1 Tf 19.3536 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 256.479 361.814 Tm (2)Tj 9.963 0 0 9.963 260.164 363.458 Tm [(-a)19.2(go)15.5(n-)]TJ -20.264 -1.0584 TD [(is)17.7(ts)-426.2(se)13.9(em)17.7(ed)-428.7(to)-430.7(be)-428.7(th)18.9(e)-433.7(c)0(a)14.7(u)0(s)20(e)-439.3(of)-429.9(di)18.9(mi)15.7(ni)18.9(sh)14.4(ed)-423(co)15.1(nt)18.9(ro)14(l)-435.6(o)0(v)15.5(e)0(r)]TJ T* [(as)19.6(th)13.2(ma)-266.8([7)19.6(])-286.9(a)0(n)-7.6(d)-285.3(a)-285.7(relativel)-13.5(y)-285.3(rapid)-292.7(decline)-290.2(in)-288.4(lung)-290(funct)-8.2(ion)]TJ 0 -1.0528 TD [([8].)-432.7(Partly)-431.7(b)-6.5(ecause)-434.2(of)-429.9(this,)-430.5(there)-435.4(was)-428.9(grow)-8.6(ing)-431.5(concern)]TJ 0 -1.0584 TD [(regard)-8.6(ing)-226.6(the)-227(possible)-229.9(harm)-8.2(ful)-222.5(effects)-223.9(of)-225.1(prolo)-7.8(nged)-225.4(use)-225.8(of)]TJ T* [(these)-309.8(drugs.)-308.6(Althoug)-8.3(h)-308.1(these)-309.8(findings)-309.6(wer)-8.2(e)-302.8(not)-306.3(suppor)-7.4(ted)]TJ T* [(by)-263.3(other)-270(studies)-269([9\26112])-7.8(,)-262.1(physicians)-271.7(\(and)-266.8(patients\))-273.7(had)-264.5(the)]TJ T* [(feeling)-325.5(that)-321.2(the)-318.1(recent)-9.8(ly)-316.9(introduced)-327.8(long-)-7.8(acting)]TJ /F3 1 Tf 19.2853 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 255.912 288.057 Tm (2)Tj 9.963 0 0 9.963 259.653 289.701 Tm (-agon-)Tj -20.2128 -1.0584 TD [(ists)-237.8(shoul)-7.4(d)-234.1(b)0(e)-229.6(u)-6.5(sed)-231.5(wi)-7.8(th)-231.5(due)-236(cauti)-9.4(on.)-235.2(Further)-238.1(studies)-240.5(wer)-8.2(e)]TJ T* [(there)-8.6(fore)-262.7(requi)-8.2(red.)-266.4(It)-261.6(turned)-265(out)-266.4(that)-264.3(prolo)-7.8(nged)-265.2(use)-260(of)-264.9(not)]TJ T* [(only)-625.7(short-act)-11.1(ing)]TJ /F3 1 Tf 7.7391 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 140.882 256.422 Tm (2)Tj 9.963 0 0 9.963 144.624 258.066 Tm [(-agoni)-9(sts,)-622(but)-619.3(also)-627.3(a)-615.8(long-)-7.8(acti)-8.6(ng)]TJ -8.6667 -1.0584 TD [(agonis)-8.6(t)-304.7(led)-312.4(to)-305.5(a)-308.5(decreas)-9.7(e)-302.8(i)0(n)-311.2(the)-306.7(prote)-8.2(ctive)-311(effects)-303.5(agains)-9(t)]TJ 0 -1.0528 TD [(broncho)-7.3(const)-7.8(rictive)-157.1(stimul)-10.4(i)-151.1(i)0(n)-151.9(the)-153(long)-153.4(term)-152.8([13,)-152.2(1)-6.5(4].)-151.5(How-)]TJ 0 -1.0584 TD [(ever)28.7(,)-193.9(this)-191.1(was)-195.6(not)-186.8(a)-6.9(ccompanied)-196.9(by)-195(an)-189.7(increase)-195(in)-191.7(bronchi)-9.7(al)]TJ T* [(hyperr)-8.2(espons)-7.4(iveness)-301.1(or)-293.3(a)-297.1(dimini)-9.2(shed)-294.9(broncho)-7.3(dila)-8.2(tory)-297.3(ef-)]TJ T* [(fect)-258.2(of)-259.2(these)-258.6(long-acti)-10.7(ng)-251.9(d)-6.5(rugs)-256.2([14,)-254.7(15].)-260.3(Althoug)-8.3(h,)-251.5(a)-6.9(t)-253.5(first)]TJ T* [(sight,)-431.2(this)-430.1(last)-430.5(aspect)-436.2(seems)-431.2(positive)-9.1(,)-427.2(i)0(t)-427.4(simu)-9.8(ltaneousl)-10.3(y)]TJ T* [(reinfo)-10.6(rces)-154.6(the)-153(idea)-154.2(that)-156.2(these)-156.1(very)-153(effective)-153(broncho)-7.3(dilators)]TJ T* [(may)-216.4(mask)-218.3(the)-221.3(severity)-219.3(of)-219.4(the)-215.6(disease)-221.9(in)-214.5(the)-215.6(long)-216(run.)-220.5(After)]TJ T* [(all,)-309.4(the)-306.7(long-)-7.8(actin)-9.4(g)]TJ /F3 1 Tf 7.8757 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 142.242 161.575 Tm (2)Tj 9.963 0 0 9.963 145.984 163.219 Tm [(-adren)-8.6(ergic)-304.5(agonists)-309.6(ha)-7.6(ve)-303.5(not)-312(been)]TJ 16.3945 44.5741 TD [(show)-8.2(n)-308.1(t)0(o)-311.2(have)-311.2(a)-308.5(broad)-313.1(an)-7.6(ti-inflammato)-15(ry)-310.4(effect.)-307.7(Signi)-7.8(fi-)]TJ 0 -1.0527 TD [(can)-8.8(t)-293.4(exposur)-8.5(e)-291.4(t)0(o)-294.1(irritant)-13.5(s)-292.2(\()]TJ /F6 1 Tf 10.5673 0 TD (e.g.)Tj /F5 1 Tf 1.7356 0 TD [(allergens)-294.5(or)-293.3(smok)-7.4(e\))-293.7(might)]TJ -12.303 -1.0471 TD [(une)-8.4(xpectedly)-246.2(cause)-245.2(a)-240.2(serious)-245.4(obstructi)-11.5(on,)-240.9(with)-239.4(the)-244.1(patient)]TJ 0 -1.0528 TD [(not)-175.4(noticing)-178.7(any)-167.7(d)-6.5(eterioration)-182.4(in)-168.9(thei)-8.2(r)-167.4(condit)-9.7(ion)-169.7(at)-175(the)-170.1(time,)]TJ 0 -1.0471 TD [(bec)-8.8(ause)-420.5(all)-422.9(symp)-7.4(toms)-419.5(are)-425.8(suppre)-7.8(ssed)-421.2(so)-418.1(effectively)-424.4(by)]TJ 0 -1.0527 TD [(these)-275.7(long-)-7.8(acting)-271.9(drugs.)-274.4(Moreo)-7.8(ver)29.9(,)-267.8(there)-276.1(is)-266.9(a)-268.6(risk)-275.7(that)-270(the)]TJ T* [(absence)-383.7(of)-373(symptom)-9.5(s)-371.8(will)-378.3(lead)-376.1(to)-373.8(less)-378.1(complianc)-10.3(e)-371.1(with)]TJ 0 -1.0471 TD [(regard)-230.5(to)-220.2(inhaled)-227.1(corticost)-11.9(eroids,)-226.8(which)-221.1(have)-225.8(just)-225.2(the)-221.3(anti-)]TJ 0 -1.0528 TD [(infl)-9.4(ammator)-10.7(y)-330.8(effect)-330(that)]TJ /F3 1 Tf 10.0893 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 415.389 521.915 Tm (2)Tj 9.963 0 0 9.963 419.131 523.559 Tm [(-agonists)-340.4(do)-337.3(not)-334.7(have.)]TJ /F7 1 Tf -10.3625 -3.8582 TD [(The)-336.7(place)-342(of)-333.2(long-a)-7.8(cting)]TJ /F3 1 Tf 10.7551 0 TD (b)Tj /F7 1 Tf 7.472 0 0 6.641 428.598 483.477 Tm (2)Tj 9.963 0 0 9.963 432.34 485.121 Tm [(-adrenergic)-331.5(agon)-8(ists)-333.8(in)]TJ -6.1344 -1.0471 TD [(the)-333.6(treatment)-338.8(of)-333.2(asthm)-8.2(a)]TJ /F5 1 Tf -5.2125 -2.4526 TD [(Th)17.1(e)-206(a)0(b)15.1(o)0(v)21.2(e)0(-)13.5(m)0(e)17.7(n)0(t)18.9(i)0(o)18.9(n)0(e)15.1(d)-205.6(co)20.8(ns)14.4(id)18.9(er)19.2(at)12.8(io)18.8(ns)-196.2(le)18.5(d)-205.6(t)0(o)-197.4(a)-206(si)17.7(tu)18.9(at)18.5(io)18.8(n)-205.6(i)0(n)]TJ -1.0015 -1.0471 TD [(wh)17.3(ic)12.8(h,)-234.5(in)-237.2(al)18.4(l)-247.8(i)0(n)18.9(t)0(e)18.4(r)0(n)13.9(a)0(t)18.4(i)0(o)18.8(n)0(a)15.1(l)-242.1(gu)15.5(id)18.9(el)18.5(in)18.9(es)13.9(,)-245.1(l)0(o)18.9(n)0(g)15.5(-)0(a)19.2(c)0(t)18.5(i)0(n)18.9(g)]TJ /F3 1 Tf 19.3536 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 507.572 438.123 Tm (2)Tj 9.963 0 0 9.963 511.2 439.823 Tm [(-a)19.2(go)15.5(n-)]TJ -20.264 -1.0527 TD [(is)17.7(ts)-460.3(ar)19.2(e)-467.8(r)0(e)13.5(s)0(e)19.6(r)0(v)19.6(e)0(d)-462.9(f)0(o)19.6(r)-469(mo)18.1(de)15.1(ra)19.2(te)18.5(-t)17.3(o-)13.9(se)19.6(ve)20.8(re)-458.8(ch)15.1(ro)19.6(ni)13.2(c)-462.1(a)0(s)14(t)0(h)18.9(m)0(a)]TJ 0 -1.0471 TD [(an)15.1(d)-205.6(a)0(l)18.5(w)0(a)16.9(y)0(s)-201.9(a)0(n)20.8(d)-205.6(ex)15.1(cl)18.5(us)20(iv)13.2(el)18.4(y)-205.6(p)0(r)19.6(e)0(s)13.9(c)0(r)19.2(i)0(b)18.9(e)0(d)-201.1(i)0(n)-197.4(c)0(o)20.8(m)0(b)12.4(i)0(n)18.8(a)0(t)18.4(i)0(o)18.8(n)-205.6(wi)14.9(th)]TJ 0 -1.0528 TD [(in)13.2(ha)20.8(le)18.4(d)-450.3(c)0(o)20.8(r)0(t)17.3(i)0(c)12.8(o)0(s)20(t)0(e)18.4(r)0(o)13.9(i)0(d)18.9(s)-445.8([1)13.9(6\26117].)-449.7(In)-458.4(pract)-8.6(ice,)-461.1(this)-458.6(means)]TJ 0 -1.0471 TD [(that)-292.7(long-acti)-10.7(ng)-280.4(agonis)-8.6(ts)-283.9(are)-289.2(only)-284.3(prescr)-9.8(ibed)-284.7(when)-291.9(short-)]TJ 0 -1.0527 TD [(acti)-8.6(ng)-280.4(agonis)-8.6(ts)-283.9(and)-281.5(inhaled)-289.7(corticosteroi)-13.6(ds)-281.6(\(the)-286.3(latter)-287.3(at)-283.2(a)]TJ 0 -1.0471 TD [(dose)-300.6(of)-299(400)-8(\261800)]TJ /F3 1 Tf 7.0506 0 TD (m)Tj /F5 1 Tf 0.5747 0 TD [(g)-296.7(daily\))-301.6(do)-297.4(not)-300.6(produce)-303.7(sufficient)-298.8(eff-)]TJ -7.6253 -1.0527 TD [(ect.)-364.4(In)-355.9(such)-363.2(cases,)-360.6(it)-359.1(is)-363.6(advisable)-366.8(to)-356.7(furt)-8.6(her)-357.1(incre)-8.6(ase)-357.1(the)]TJ 0 -1.0471 TD [(dose)-488.3(of)-481.1(inhal)-9(ed)-479.9(corti)-10.6(costeroids)-489.5(or)-486.8(add)-480.7(long-)-7.8(acting)]TJ /F3 1 Tf 21.5501 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 529.512 354.444 Tm (2)Tj 9.963 0 0 9.963 533.253 356.145 Tm (-)Tj -22.4777 -1.0528 TD [(ago)-8.4(nists)-335.3(\(fig)-8.6(.)-330.4(1\).)]TJ ET 0 G 1 J 1 j 0.454 w 10 M []0 d 58.28 142.186 m 185.783 142.186 l S BT 7.97 0 0 7.97 58.28 129.487 Tm [(Corresponde)11.8(nce:)-368.9(C.P)109.4(.)-376(van)-362.6(Schayck,)-363.1(University)-366(of)-365.9(Maastricht,)-366.6(Dept)-365.3(of)]TJ 0 -1.067 TD [(General)-286(Practice,)-286.7(P)103.9(.O.)-289.9(Box)-290.1(616,)-291.4(6200)-283.2(MD)-289(Maastricht,)-288.4(the)-286.7(Netherlands.)]TJ 0 -1.0599 TD [(Fax:)-332.2(31)-330.1(4338842)14.7(25.)]TJ /F13 1 Tf 10 0 0 10 311.014 170.316 Tm 0 0 0 1 k /GS3 gs (Phase 1)Tj 4.0637 -0.02 TD 0.0035 Tc [(Shor)-40(t-acting )]TJ /F10 1 Tf 4.7348 0 TD 0 Tc (b)Tj /F13 1 Tf 8 0 0 8 404.524 167.281 Tm (2)Tj 10 0 0 10 408.2 170.116 Tm 0.0035 Tc [(-adrenergic agonist "if necessar)-30(y")]TJ ET 0 0 0 1 K 0 J 0 j 0.5 w 3.864 M /GS4 gs 345.265 182.116 188.503 -17 re S BT 10 0 0 10 311.014 205.918 Tm /GS3 gs 0 Tc (Phase 2)Tj 4.0637 0.3333 TD (ICS 400\320800 )Tj /F10 1 Tf 5.015 0 TD (m)Tj /F13 1 Tf 0.576 0 TD [(g and shor)-40(t-acting )]TJ /F10 1 Tf 6.832 0 TD (b)Tj /F13 1 Tf 8 0 0 8 481.369 206.417 Tm (2)Tj 10 0 0 10 485.017 209.251 Tm (-adrenergic)Tj -13.3367 -1 TD [(agonist "if necessar)-30(y")]TJ ET /GS4 gs 345.265 219.852 188.503 -23.5 re S BT 10 0 0 10 311.014 256.32 Tm /GS3 gs (Phase 3)Tj 4.0637 1.3067 TD (ICS >800 )Tj /F10 1 Tf 3.67 0 TD (m)Tj /F13 1 Tf 0.576 0 TD [(g and shor)-40(t-acting )]TJ /F10 1 Tf 6.832 0 TD (b)Tj /F13 1 Tf 8 0 0 8 467.919 266.552 Tm (2)Tj 10 0 0 10 471.567 269.387 Tm (-adrenergic)Tj -11.9917 -1 TD [(agonist, "if necessar)-30(y" )]TJ /F15 1 Tf 8.315 0 TD (or)Tj /F13 1 Tf 0.729 0 TD ( ICS 400\320800 )Tj /F10 1 Tf 5.243 0 TD (m)Tj /F13 1 Tf 0.576 0 TD (g and)Tj -14.863 -1 TD (long-acting )Tj /F10 1 Tf 4.239 0 TD (b)Tj /F13 1 Tf 8 0 0 8 399.53 246.552 Tm (2)Tj 10 0 0 10 403.178 249.387 Tm [(-agonist, with shor)-40(t-acting)]TJ /F10 1 Tf -5.1528 -1 TD (b)Tj /F13 1 Tf 8 0 0 8 357.14 236.552 Tm (2)Tj 10 0 0 10 360.788 239.387 Tm [(-agonist "if necessar)-30(y")]TJ ET /GS4 gs 345.265 279.954 188.503 -45.5 re S BT 10 0 0 10 311.014 311.389 Tm /GS3 gs (Phase 4)Tj 4.0468 0.78 TD -0.0104 Tc (ICS >800 )Tj /F10 1 Tf 3.5762 0 TD 0 Tc (m)Tj /F13 1 Tf 0.5655 0 TD -0.0104 Tc (g and long-acting )Tj /F10 1 Tf 6.3314 0 TD 0 Tc (b)Tj /F13 1 Tf 8 0 0 8 461.598 316.355 Tm (2)Tj 10 0 0 10 465.163 319.19 Tm -0.0104 Tc (-adrenergic)Tj -11.3682 -1 TD [(agonist, or)10(al steroids)15(, ipr)10(atropium, with shor)-40(t-acting)]TJ /F10 1 Tf T* 0 Tc (b)Tj /F13 1 Tf 8 0 0 8 356.867 296.355 Tm (2)Tj 10 0 0 10 360.432 299.19 Tm -0.0104 Tc [(-agonist "if necessar)-30(y")]TJ ET /GS4 gs 345.265 329.69 188.503 -35 re S 3.864 M 435.816 293.257 m 435.816 285.257 l S 435.816 285.548 m 437.566 285.548 l 435.816 281.174 l 434.066 285.548 l 435.816 285.548 l f* 435.816 233.056 m 435.816 225.056 l S 435.816 225.348 m 437.566 225.348 l 435.816 220.973 l 434.066 225.348 l 435.816 225.348 l f* 435.816 195.222 m 435.816 187.222 l S 435.816 187.514 m 437.566 187.514 l 435.816 183.139 l 434.066 187.514 l 435.816 187.514 l f* BT /F5 1 Tf 7.97 0 0 7.97 309.316 153.184 Tm 0 g /GS2 gs 0 Tc [(Fig.)-334.3(1.)-324.1(\261)-332.2(Current)-361.6(phased)-356.4(plan)-362.9(\(simplified\))-362.3(for)-356.8(the)-365(treatment)-362.6(of)-358.8(asthma)]TJ 0 -1.067 TD [(based)-515(on)-508(Global)-512.9(Initiative)-508.3(for)-513.3(Asthma)-504.9(guidelines)-511.7([16].)-510.2(The)-507.5(arrows)]TJ 0 -0.9958 TD [(indicate)-449.7(that)-450.6(the)-450.3(medication)-445.7(can)-446.9(be)-450(gradually)-446.4(decreased,)-445.8(if)-446.5(possible.)]TJ 0 -1.003 TD [(Phase)-278.1(4:)-282.7(severe)-284.5(persistent)-278.3(asthma;)-274(phase)-280.3(3:)-282.7(moderate)-274.6(persistent)-278.3(asthma;)]TJ 0 -0.9958 TD [(phase)-486.6(2:)-481.9(mild)-487.5(persistent)-477.5(asthma;)-480.3(phase)-486.6(1:)-481.9(intermittent)-485.4(asthma.)-479(ICS:)]TJ 0 -1.0029 TD [(inhaled)-329.5(corticosteroids)8.1(.)]TJ ET 58.28 142.186 83.452 -0.51 re f* BT /F4 1 Tf 6.974 0 0 6.974 58.28 797.499 Tm 0.0001 Tc [(Eur)-334.8(Respir)-337.8(J)-337.2(2000;)-339.7(15:)-330.1(631\261634)]TJ 0 -1.1462 TD 0 Tc [(Printed)-341.4(i)0(n)-335.6(U)-0.1(K)-331.2(\261)-334.1(all)-337(rights)-335.9(r)0(e)-9.2(s)0(erved)]TJ 52.703 2.2844 TD 0.0001 Tc (Copyright)Tj /F8 1 Tf 5.928 0 0 5.928 457.909 806.456 Tm 0 Tc (#)Tj /F4 1 Tf 6.974 0 0 6.974 463.805 805.436 Tm 0.0001 Tc [(ERS)-339.8(Journals)-337.8(L)0(td)-338.3(2000)]TJ -4.4305 -1.1381 TD [(European)-338.6(Res)-10.1(piratory)-336.9(Journal)]TJ 3.2843 -1.1462 TD [(ISSN)-335.2(0903-1936)]TJ ET endstream endobj 3 0 obj << /ProcSet [/PDF /Text ] /Font << /F1 4 0 R /F2 5 0 R /F3 6 0 R /F4 7 0 R /F5 8 0 R /F6 9 0 R /F7 10 0 R /F8 11 0 R /F10 12 0 R /F13 13 0 R /F15 14 0 R >> /ExtGState << /GS2 15 0 R /GS3 16 0 R /GS4 17 0 R >> >> endobj 20 0 obj << /Length 25171 >> stream BT /F5 1 Tf 9.963 0 0 9.963 68.258 771.647 Tm 0 g /GS2 gs 0 Tc [(As)-467.6(pa)15.1(ti)16.5(en)20.8(ts)-471.7(se)19.6(em)-471.7(to)-464.8(be)15.1(ne)20.8(fi)17.3(t)-481.2(c)0(o)20.8(n)0(s)14.4(i)13.9(de)15.1(ra)19.2(bl)13.2(y)-473.1(f)0(r)18(o)0(m)-471.3(l)0(o)18.8(n)0(g)15.5(-)]TJ -1.0015 -1.0755 TD [(ac)14.7(t)13.9(i)0(n)13.2(g)]TJ /F3 1 Tf 2.5721 0 TD 0 Tw (b)Tj /F5 1 Tf 7.472 0 0 6.641 89.348 759.288 Tm (2)Tj 9.963 0 0 9.963 92.976 760.932 Tm [(-a)19.2(go)15.5(ni)18.9(st)17.7(s)-206.8(a)0(n)20.8(d)-205.6(th)18.9(es)13.9(e)-200.3(c)0(a)14.7(n)-199.9(be)-195.4(us)14.4(ed)-195.4(qu)21.2(it)16.5(e)-206(s)0(i)17.7(m)0(p)18.1(l)0(y)-197.4(t)0(w)20.6(i)0(c)12.8(e)]TJ -3.4826 -1.0698 TD [(a)-245.9(d)0(a)15.1(y)73.2(,)-245.1(t)0(h)18.9(e)-245.9(op)15.5(t)13.9(i)0(o)13.2(n)-245.5(to)-237.2(le)18.4(t)-242.1(t)0(h)13.2(e)0(s)19.6(e)-245.9(dr)19.6(ug)15.5(s)-246.7(p)0(l)18.9(a)0(y)-235.2(a)-245.9(mo)18.1(re)-242.5(ce)20.4(nt)18.9(ra)13.5(l)-242.2(r)0(o)14(l)0(e)]TJ 0 -1.0755 TD [(in)-254.3(th)13.2(e)-262.9(t)0(r)17.3(e)0(a)14.7(t)13.9(me)12(nt)-254.3(of)-259.2(as)19.6(th)18.9(ma)-255.5(is)-261.2(ce)20.4(rt)17.3(ai)18.4(nl)13.2(y)-262.5(a)0(t)18.4(t)0(r)17.3(a)0(c)14.7(t)0(i)16.5(v)0(e)20.8(.)-267.8(It)-255.9(is)-255.5(th)18.8(en)15.1(,)]TJ T* [(of)-435.6(co)20.8(ur)13.9(se)19.6(,)-444.2(i)0(m)15.7(p)0(o)21.2(r)0(t)11.6(a)0(n)20.8(t)-447(t)13.9(h)0(a)15.1(t)-441.3(th)13.2(is)-431.9(wi)14.9(ll)-433.1(no)15.5(t)-441.3(l)0(e)12.8(a)0(d)-434.4(t)0(o)-430.7(t)0(h)13.2(e)-439.3(ri)17.3(sk)14.4(s)]TJ T* [(al)18.4(re)13.5(ad)20.8(y)-325.1(m)0(e)17.7(n)0(t)18.9(i)0(o)13.2(n)0(e)20.8(d)0(.)]TJ 1.0015 -1.0471 TD [(T)69.1(o)-279.6(fu)19.6(rt)17.3(he)15.1(r)-281.2(e)0(x)15.1(a)0(m)17.7(i)0(n)18.9(e)-280(th)18.9(e)-285.7(p)0(l)18.9(a)0(c)14.7(e)-280(of)-270.6(lo)18.9(ng)15.5(-a)19.2(ct)18.4(in)13.2(g)]TJ /F3 1 Tf 17.3903 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 246.898 706.053 Tm (2)Tj 9.963 0 0 9.963 250.583 707.697 Tm [(-a)19.2(go)15.5(ni)18.9(st)17.7(s)]TJ -19.3023 -1.0755 TD [(in)-203.1(th)13.2(e)-211.7(t)0(r)17.3(e)0(a)14.7(t)0(m)15.7(e)0(n)20.8(t)-213.7(of)-208(as)13.9(t)13.9(h)0(m)12.4(a)-211.7(\(s)18.4(ee)-207.2(th)18.9(e)-217.4(p)0(h)15.5(a)0(s)19.6(e)0(d)-206.8(p)0(l)18.9(a)0(n)-206.8(i)0(n)-203.1(f)0(i)17.3(g)0(u)15.5(r)0(e)-208.4(1\),)]TJ 0 -1.0698 TD [(large-scale)-287(and)-292.9(well-con)-11.5(trolled)-293.3(international)-297.8(studi)-9.8(es)-287.7(have)]TJ 0 -1.0755 TD [(been)-186(carried)-188.5(out)-181.1(over)-181.5(the)-181.5(p)-6.5(ast)-182.7(few)-178.9(ye)-7.6(ars)-181.9([18\26120])-8.5(.)-176.8(The)-183.2(com-)]TJ T* [(bination)-184.4(of)-173.8(a)-177.6(long-acti)-10.7(ng)]TJ /F3 1 Tf 9.7308 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 160.724 663.25 Tm (2)Tj 9.963 0 0 9.963 164.466 664.894 Tm [(-adren)-8.6(ergic)-167.9(agon)-9.1(ist)-173.3(\(sal)-8.6(meterol)]TJ -10.6584 -1.0755 TD (100)Tj /F3 1 Tf 1.7811 0 TD (m)Tj /F5 1 Tf 0.5747 0 TD [(g)-279.6(dail)-8.2(y\))-282(and)-281.5(an)-280.8(inhal)-9(ed)-280.8(corticost)-11.9(eroid)-287(\(beclomet)-11.9(ha-)]TJ -2.3559 -1.0698 TD [(sone)-186.7(400)]TJ /F3 1 Tf 3.6989 0 TD (m)Tj /F5 1 Tf 0.5747 0 TD [(g)-182.9(dail)-8.2(y\))-185.2(was)-189.9(compa)-7.8(red)-186.4(with)-193.8(a)-183.3(higher)-191.1(dose)-192.4(of)-185.2(the)]TJ -4.2736 -1.0755 TD [(steroid)-326.3(\(1,000)]TJ /F3 1 Tf 5.9068 0 TD (m)Tj /F5 1 Tf 0.5747 0 TD [(g)-319.4(daily\))-324.3(alone)-320([18].)-325.3(Peak)-321.8(flow)-323.9(imp)-7.8(roved)]TJ -6.4815 -1.0755 TD [(and)-218.9(symp)-7.4(toms)-220.3(decreas)-9.7(ed)-218.2(when)-217.9(the)-221.3(combinati)-12.3(on)-217.8(of)-213.7(ster)-8.6(oid)]TJ T* [(and)-332.7(long-ac)-10.1(ting)]TJ /F3 1 Tf 6.6181 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 129.713 609.732 Tm (2)Tj 9.963 0 0 9.963 133.455 611.376 Tm [(-agonist)-338.4(was)-332.2(used.)-329.4(In)-333.2(anothe)-7.8(r)-326.7(tri)-8.6(al)-328.7(in-)]TJ -7.5457 -1.0698 TD [(volvin)-9.3(g)-154.4(patients)-163.2(with)-159.7(more)-161.8(severe)-162.2(asthma)-165.7(who)-159.9(could)-160.2(not)-158.3(be)]TJ 0 -1.0755 TD [(treated)-354.3(effectively)-350.4(with)-353.2(1,000)]TJ /F3 1 Tf 12.2859 0 TD (m)Tj /F5 1 Tf 0.5747 0 TD [(g)-347.9(inhale)-10.1(d)-342.2(corti)-10.6(costeroids)]TJ -12.8606 -1.0755 TD [(daily)-151.2(alone,)-149.6(two)-150.9(dif)10.8(ferent)-153.2(combi)-9.7(nations)-148.3(o)-6.5(f)-144.6(a)-143.4(long-)-7.8(acting)]TJ /F3 1 Tf 21.5501 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 278.475 577.644 Tm (2)Tj 9.963 0 0 9.963 282.217 579.288 Tm (-)Tj -22.4777 -1.0698 TD [(agonis)-8.6(t)-236.5(a)0(n)-7.6(d)-239.8(inhaled)-244.2(corti)-10.6(costeroid)-248.5(\(salmet)-11.1(erol)-240.7(100)]TJ /F3 1 Tf 20.0478 0 TD (m)Tj /F5 1 Tf 0.5691 0 TD [(g)-245.5(and)]TJ -20.6169 -1.0755 TD [(beclom)-10.9(ethasone)-272.7(1,000)]TJ /F3 1 Tf 9.1845 0 TD (m)Tj /F5 1 Tf 0.5747 0 TD [(g)-268.2(daily)]TJ /F6 1 Tf 3.016 0 TD (versus)Tj /F5 1 Tf 2.7997 0 TD [(salm)-10.2(eterol)-273.5(200)]TJ /F3 1 Tf 6.1515 0 TD (m)Tj /F5 1 Tf 0.5747 0 TD (g)Tj -22.3013 -1.0755 TD [(and)-162(be)-7.6(clomethas)-11.5(one)-162(1,000)]TJ /F3 1 Tf 10.5787 0 TD (m)Tj /F5 1 Tf 0.5691 0 TD [(g)-165.8(daily\))-165(wer)-8.2(e)-160.5(compa)-7.8(red)-163.6(wi)-7.8(th)-163.2(a)]TJ -11.1478 -1.0755 TD [(high)-358.2(dose)-363.2(of)-355.9(the)-357.9(inhal)-9(ed)-354.7(corti)-10.6(costeroid)-362.3(\(2,000)]TJ /F3 1 Tf 19.0633 0 TD (m)Tj /F5 1 Tf 0.5747 0 TD [(g)-353.6(dail)-8.2(y\))]TJ -19.6381 -1.0698 TD [(alone)-308.6([19].)-313.9(Again,)-312.5(addition)-315.2(of)-304.7(the)-312.4(long-acti)-10.7(ng)]TJ /F3 1 Tf 18.6764 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 249.846 524.126 Tm (2)Tj 9.963 0 0 9.963 253.587 525.827 Tm [(-agoni)-9(st)]TJ -19.6039 -1.0755 TD [(clear)-9(ly)-328.3(proved)-330.9(to)-328.3(lead)-330.6(to)-334(a)-325.5(great)-8.6(er)-327.9(improvem)-11.1(ent)-329.4(in)-328.3(sym-)]TJ T* [(ptoms)-181.2(and)-173.4(peak)-180.3(flow)-176(than)-176.6(did)-175.4(the)-181.5(increased)-184.4(dose)-175.4(of)-173.8(inhal)-9(ed)]TJ T* [(corticost)-11.9(eroid)-8.2(s)-229.6(o)0(n)-234.8(its)-235.9(own.)-239.9(The)-234.4(higher)-242.3(dosage)-239.9(of)-230.7(the)-238.4(long-)]TJ 0 -1.0698 TD [(acting)-186.6(agonist)-182.4(\(sal)-8.6(meterol)-186.4(200)]TJ /F6 1 Tf 11.9445 0 TD (versus)Tj /F5 1 Tf 2.7144 0 TD (100)Tj /F3 1 Tf 1.6787 0 TD (m)Tj /F5 1 Tf 0.5747 0 TD [(g)-177.2(dail)-8.2(y\))-179.5(did)-181.1(not)]TJ -16.9123 -1.0755 TD [(prove)-341.6(to)-334(be)-332(of)-338.9(any)-332.7(addit)-9(ional)-339(value.)]TJ 1.0015 -1.0471 TD [(Al)14.9(th)18.9(ou)15.5(gh)-200.7(bo)21.2(th)-203.1(tr)17.3(ia)18.4(ls)-204.3(we)16.9(re)-202.7(we)16.9(ll)-205.5(se)19.6(t)-213.7(u)0(p)21.2(,)-210.9(th)18.9(ey)-201.1(mi)15.7(gh)15.5(t)-208(b)0(e)-206.8(c)0(r)19.2(i)0(t)16.5(-)]TJ -1.0015 -1.0755 TD [(ic)18.4(iz)18.4(ed)-229.6(be)15.1(ca)20.4(us)14.4(e)-234.5(t)0(h)18.9(e)0(y)-229.6(c)0(o)15.1(v)0(e)20.8(r)0(e)13.5(d)-234.1(a)-240.2(p)0(e)20.8(r)0(i)17.3(o)0(d)-229.2(o)0(f)-230.7(o)0(n)21.2(l)0(y)-231.5(6)-234.1(mo)18.1(nt)18.9(hs)-230.3(an)15.1(d)]TJ T* [(be)15.1(ca)20.4(us)14.4(e)-211.7(t)0(h)18.9(e)-211.7(pr)13.9(im)15.7(ar)19.2(y)-211.3(o)0(u)15.5(t)0(c)18.4(o)0(m)18.1(e)-217.4(w)12.4(a)0(s)-208(e)0(v)20.8(a)0(l)12.8(u)0(a)20.8(t)0(e)18.4(d)-217(on)-200.7(th)13.2(e)-211.7(b)0(a)20.8(s)0(i)17.7(s)-218.2(of)]TJ T* [(lu)18.9(ng)-189.3(fu)13.9(nc)20.8(ti)16.5(on)-189.3(an)20.8(d)-199.9(s)0(y)14.4(m)0(p)18.1(t)0(o)18.9(m)0(s)-188(a)0(t)-192.1(a)-200.3(ti)16.5(me)-187.2(wh)17.3(en)-189.7(th)18.9(e)-200.3(l)0(o)18.9(n)0(g)15.5(-)0(a)19.2(c)0(t)18.4(i)0(n)13.2(g)]TJ 0 -1.0698 TD [(ag)15.1(on)21.2(is)17.7(ts)-357.9(we)16.9(re)-356.3(st)12(i)13.9(l)0(l)-359.1(a)0(c)14.7(t)0(i)16.5(v)0(e)-354.7(t)0(o)-356.7(s)0(o)14.4(m)0(e)-357.9(e)0(x)20.8(t)0(e)18.4(n)0(t)13.2(.)-364.6(T)12.2(h)0(u)15.5(s)0(,)-355.2(a)0(l)12.8(t)13.9(ho)15.5(ug)15.5(h)]TJ 0 -1.0755 TD [(sy)20(mp)12.4(to)18.9(ms)-330.2(ma)17.7(y)-342.2(h)0(a)20.8(v)0(e)-332(d)0(e)15.1(c)0(r)19.2(e)0(a)14.7(s)0(e)19.6(d)-342.2(an)20.8(d)-342.2(l)0(u)18.9(n)0(g)-331.6(f)0(u)19.6(n)0(c)15.1(t)0(i)22.2(o)0(n)-331.6(i)0(m)15.7(p)0(r)13.9(o)0(-)]TJ T* [(ve)15.1(d)-251.2(d)0(u)15.5(r)0(i)17.3(n)0(g)-246.2(t)13.9(he)-246.6(us)14.4(e)-251.6(o)0(f)-247.8(t)0(h)18.9(e)0(s)19.6(e)-257.2(dr)19.6(ug)15.5(s,)-247(t)13.9(h)0(e)15.1(r)0(e)-248.2(s)0(t)17.7(i)0(l)16.5(l)-253.5(re)19.2(ma)17.7(in)13.2(s)-252.3(a)-257.2(ri)17.3(sk)]TJ T* [(th)18.9(at)-118.1(th)18.9(es)13.9(e)-126.4(o)0(u)21.2(t)0(c)18.4(o)0(m)12.4(e)0(s)-116.9(a)0(r)19.2(e)-126.4(ma)17.7(sk)14.4(in)18.9(g)-126(p)0(o)21.2(s)0(s)13.2(i)0(b)18.9(l)0(e)-118.1(u)0(n)21.2(d)0(e)15.1(r)0(l)17.3(y)0(i)18.9(n)0(g)-115.3(i)0(n)13.2(f)0(l)17.3(a)0(m)17.7(-)]TJ 0 -1.0698 TD [(ma)17.7(to)18.9(ry)-276.3(pr)14(oc)20.8(es)13.9(se)19.6(s)-286.5(o)0(r)-270.6(t)0(h)13.2(e)-280(in)13.2(cr)19.2(ea)14.7(se)-270.6(th)13.2(er)19.2(eo)15.1(f.)-270.2(Wh)14.4(en)-275.1(co)15.1(nt)18.9(ro)19.6(l)-287.7(o)0(f)]TJ 0 -1.0755 TD [(as)19.6(th)13.2(ma)-278.2(is)-278.2(th)18.9(e)-291.4(p)0(r)19.6(i)0(m)15.7(a)0(r)19.2(y)-291(ai)18.5(m)-288.4(o)0(f)-282(a)-285.7(st)17.7(ud)21.2(y)67.5(,)-284.9(it)-279.4(is)-278.2(pa)15.1(rt)17.3(ic)18.4(ul)18.9(ar)13.5(ly)-277.1(im)15.7(-)]TJ T* [(po)15.5(rt)17.3(an)20.8(t)-236.5(t)0(o)-220.2(k)0(n)15.5(o)0(w)-227.4(w)12.4(he)15.1(th)18.9(er)-225.5(or)-225.1(no)21.2(t)-236.5(e)0(x)20.8(a)0(c)14.7(e)0(r)19.2(b)0(a)15.1(t)0(i)16.5(o)0(n)21.2(s)-235.3(oc)15.1(cu)20.8(r)-235.7(d)0(u)21.2(r)0(i)17.3(n)0(g)]TJ 0 -1.0698 TD [(th)18.9(e)-166.2(l)0(o)18.9(n)0(g)15.5(-)0(t)17.3(e)0(r)19.2(m)-168.9(us)20(e)-166.2(o)0(f)-156.8(t)0(h)18.9(e)0(s)13.9(e)-160.5(dr)14(ug)21.2(s.)-156(It)-159.1(wa)16.9(s)-167(e)0(s)19.6(p)0(e)15.1(c)0(i)18.4(a)0(l)18.4(l)0(y)-157.6(i)0(n)-157.6(v)0(i)18.9(e)0(w)-159.5(o)0(f)]TJ 25.1977 42.9067 TD [(th)13.2(is)-369.3(th)18.9(at)-368.5(th)18.9(e)-382.4(F)11.4(or)19.6(mo)12.4(te)18.4(ro)19.6(l)-378.7(a)0(n)15.1(d)-376.3(Co)16.5(rt)17.3(ic)18.5(os)20(te)12.8(ro)19.6(id)18.8(s)-377.5(E)0(s)15.9(t)0(a)18.4(b)0(l)18.9(i)0(s)12(h)0(i)18.9(n)0(g)]TJ 0 -1.0471 TD [(Th)17.1(er)13.5(ap)20.8(y)-177.2(\()0(F)88.7(A)0(C)18.3(E)0(T)13(\))-173.1(st)17.7(ud)15.5(y)-177.2(w)0(a)16.9(s)-178.4(se)19.6(t)-179.6(u)0(p)15.5(:)-173.9(a)-177.6(1)0(2)15.5(-)0(m)16.5(o)0(n)21.2(t)0(h)-168.9(t)0(r)17.3(i)0(a)12.8(l)-173.9(du)15.5(ri)17.3(ng)]TJ 0 -1.0528 TD [(wh)17.3(ic)12.8(h)-353.6(t)0(h)13.2(e)-354(ef)24.9(fe)19.2(ct)12.8(s)-354.8(o)0(f)-350.2(v)0(a)15.1(r)0(i)17.3(o)0(u)21.2(s)-360.5(do)21.2(se)14(s)-354.8(o)0(f)-350.3(a)0(n)-349.1(i)0(n)13.2(h)0(a)20.8(l)0(e)18.4(d)-359.3(co)15.1(rt)17.3(ic)18.4(o-)]TJ 0 -1.0471 TD [(st)17.7(er)13.5(oi)18.9(d)-143(\()0(b)19.6(u)0(d)15.5(e)0(s)19.6(o)0(n)15.5(i)0(d)18.9(e)-143.4(20)15.5(0)]TJ /F6 1 Tf 9.3097 0 TD [(ve)20.4(rs)18.8(us)]TJ /F5 1 Tf 2.6233 0 TD [(80)15.5(0)]TJ /F3 1 Tf 1.6275 0 TD (m)Tj /F5 1 Tf 0.5634 0 TD [(g)-143(d)0(a)15.1(i)0(l)22.2(y)0(\))13.9(,)-142.6(po)21.2(ss)13.2(ib)18.9(ly)-134.8(co)20.8(m-)]TJ -14.1239 -1.0528 TD [(bi)13.2(ne)20.8(d)-251.2(w)12.4(it)16.5(h)-251.2(a)-245.9(lo)18.8(ng)15.5(-a)19.2(ct)18.5(in)18.9(g)]TJ /F3 1 Tf 9.7536 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 411.874 728.164 Tm (2)Tj 9.963 0 0 9.963 415.502 729.808 Tm [(-a)13.5(dr)19.6(en)15.1(er)30.6(gi)18.9(c)-251.6(a)0(g)20.8(o)0(n)15.5(i)0(s)17.7(t)-247.8(\(f)18(or)13.9(mo)18.1(te)18.4(ro)19.6(l)]TJ -10.6584 -1.0471 TD (24)Tj /F3 1 Tf 1.3999 0 TD (m)Tj /F5 1 Tf 0.5634 0 TD [(g)-410.5(d)0(a)15.1(i)13.9(ly)13.2(\),)-395.4(we)16.9(re)-401.9(st)17.7(ud)15.5(ie)18.4(d)-404.8(i)0(n)-402.2(8)0(5)21.2(2)-410.5(as)19.6(th)13.2(ma)-397.7(pa)15.1(ti)16.5(en)20.8(ts)-397.8([2)14(0].)]TJ -1.9632 -1.0528 TD [(Rem)-10.6(arkably)58.2(,)-222.3(the)-221.3(long-ac)-10.1(ting)-218.4(agon)-9.1(ist)-218.8(did)-220.9(not)-220.9(on)-7.2(ly)-220.2(improve)]TJ 0 -1.0471 TD [(lung)-403.8(function)-405.5(and)-395.3(dec)-8.8(rease)-400.5(symp)-7.4(toms)-396.7(bu)-7.2(t)-395.8(also)-399.7(reduced)]TJ 0 -1.0527 TD [(the)-306.7(n)-6.5(umber)-304.9(o)-6.5(f)-304(mild)-306.9(and)-310(severe)-310.2(exacerba)-9.7(tions)-305.7(\(by)-311.2(40)-303.1(and)]TJ T* [(29%)-380.2(respec)-8.6(tive)-8.2(ly\).)-376.5(This)-380.6(was)-377.7(the)-380.7(case)-381(with)-381.6(not)-380.2(only)-375.3(the)]TJ 0 -1.0471 TD [(high)-267.2(dose)-260.7(of)-259.2(the)-261.2(inhal)-9(ed)-258(corticost)-11.9(eroid)-264.3(\(800)]TJ /F3 1 Tf 17.6293 0 TD (m)Tj /F5 1 Tf 0.5747 0 TD [(g)-262.5(daily\))-261.7(but)]TJ -18.2041 -1.0528 TD [(also)-285.9(the)-283.9(low)-281.7(dose)-283.5(\(200)]TJ /F3 1 Tf 9.3496 0 TD (m)Tj /F5 1 Tf 0.5747 0 TD [(g)-279.6(dail)-8.2(y\).)-282.3(This)-283.9(last)-282.6(observ)-7.8(ation)-287.8(is)]TJ -9.9243 -1.0471 TD [(highl)-8.6(y)-211.3(relevant,)-213.2(b)-6.5(ecause)-212.2(this)-213.9(might)-216.6(imply)-210.9(that)-213.1(the)-215.6(addition)]TJ 0 -1.0527 TD [(of)-230.7(a)-228.8(long-)-7.8(acti)-8.6(ng)]TJ /F3 1 Tf 6.4702 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 379.275 633.997 Tm (2)Tj 9.963 0 0 9.963 383.017 635.641 Tm [(-agoni)-9(st)-227(could)-234.2(be)-229.6(useful)-237.8(from)-231.3(the)-232.7(mild-)]TJ -7.3977 -1.0471 TD [(persi)-9.4(stent)-363(asthma)-359.2(stage)-366.7(\(phase)-361(2)-353.6(i)0(n)-362.4(figure)-357.7(1)-6.5(,)-353.2(in)-356.7(which)-363.3(a)]TJ 0 -1.0527 TD [(low)-350(dose)-346.1(of)-350.3(corticost)-11.9(eroids)-351.6(is)-346.5(adminis)-9.2(tered\).)-347.1(Thi)-8.8(s)-343.4(might)]TJ 0 -1.0471 TD [(lead)-148.5(to)-140.5(long-)-7.8(acti)-8.6(ng)-138.1(agon)-9.2(ists)-141.1(being)-148.9(introduced)-151.4(at)-146.6(a)-143.4(much)-143.2(ear-)]TJ 0 -1.0528 TD [(lier)-351.2(stage)-8.2(.)-347.5(Short-acti)-12.3(ng)-348.7(agonists)-349.4(mig)-7.8(ht)-345.3(then)-353(be)-343.4(prim)-10.2(arily)]TJ 0 -1.0471 TD [(reser)-9(ved)-275.8(for)-272.9(intermi)-11.9(ttent)-273.1(asthm)-10.9(a)-268.6(and)-275.8(the)-272.5(long-)-7.8(acting)-277.6(ones)]TJ 0 -1.0527 TD [(for)-267.3(persi)-9.4(stent)-266.2(asthm)-10.9(a.)-263.3(It)-267.3(should)-269.9(be)-263.7(stressed,)-270.9(howe)-7.4(ver)29.9(,)-267.8(that)]TJ 0 -1.0471 TD [(long-)-7.8(actin)-9.4(g)-461.7(agonis)-8.6(ts)-466(should)-469.1(always)-473.8(be)-462.9(admi)-9(nistered)-469.7(in)]TJ 0 -1.0528 TD [(combi)-9.7(nation)-169.1(with)-171.1(inhaled)-170.2(corticost)-11.9(eroid)-8.2(s.)-161.7(The)-166.2(dose)-169.7(of)-168.2(ster-)]TJ 0 -1.0471 TD [(oids)-302.5(may)-296.1(be)-297.8(incre)-8.6(ased)-295.3(consi)-7.8(stent)-300.4(with)-296.3(the)-301(severity)-304.7(of)-293.3(the)]TJ 0 -1.0527 TD [(asthm)-10.9(a;)-214.9(the)-215.6(F)68.3(ACET)-156.5(study)-217.9(also)-217.6(show)-8.2(s)-212.5(that)-218.8(a)-217.4(higher)-219.5(dose)-215.2(of)]TJ 0 -1.0471 TD [(inhal)-9(ed)-332(co)-7.6(rticosteroid)-12.5(s)-332(resul)-9.4(ts)-335.2(in)-334(few)-8.2(er)-333.6(exacerba)-9.7(tions.)]TJ /F6 1 Tf 0 -3.5566 TD [(Pos)-7.6(sible)-334.5(a)-6.5(daptation)-338.4(of)-339.6(the)-335.1(phased)-336.2(plan)]TJ /F5 1 Tf 1.0015 -2.7485 TD [(Th)17.1(e)-428(c)0(o)20.8(n)0(s)14.4(i)13.9(de)15.1(ra)19.2(ti)16.5(on)15.5(s)-423.1(m)0(e)17.7(n)0(t)18.9(i)0(o)18.9(n)0(e)15.1(d)-421.9(ab)15.1(ov)21.2(e)-428(m)0(a)17.7(y)-421.9(le)18.4(ad)-417.4(in)-413.6(th)18.9(e)]TJ -1.0015 -1.0528 TD [(lo)13.2(ng)-200.7(ru)13.9(n,)-200.3(to)-203.1(ad)15.1(ap)20.8(ta)12.8(ti)22.2(on)-206.4(of)-202.3(th)13.2(e)-211.7(p)0(h)21.2(a)0(s)14(e)0(d)-201.1(p)0(l)13.2(a)0(n)-201.1(\()0(f)18(i)0(g)18.9(.)-216.6(2\).)-214.1(It)-221.7(shoul)-7.4(d)]TJ 0 -1.0471 TD [(be)-269.4(empha)-7.8(sized)-275.7(that)-270(such)-272.1(adapta)-8.2(tion)-269.6(cannot)-275.2(be)-269.4(carried)-273.9(out)]TJ 0 -1.0527 TD [(wi)-7.8(thout)-219.1(first)-223.5(having)-217.9(obtai)-9(ned)-213.2(the)-221.3(results)-225(of)-213.7(wel)-9(l)-213.7(contr)-8.2(olled)]TJ 0 -1.0471 TD [(tri)-8.6(als)-313.6(conduct)-8.5(ed)-314.9(over)-318(a)-314.2(perio)-8.2(d)]TJ /F3 1 Tf 12.3599 0 TD (>)Tj /F5 1 Tf 0.552 0 TD [(12)-314.5(months.)-319(T)63.4(o)-313.8(prevent)-323.1(a)]TJ -12.9119 -1.0527 TD [(dec)-8.8(rease)-377.7(in)-373.8(compl)-9.7(iance)-377.3(wi)-7.8(th)-373.8(regard)-378.5(to)-379.5(inhaled)-380.8(corticos-)]TJ 0 -1.0471 TD [(teroi)-10.6(ds)-537.6(a)-6.9(s)-536.9(a)-541.8(resul)-9.4(t)-538.1(o)0(f)-543.7(the)-545.7(efficacy)-536.8(of)-543.7(long-)-7.8(acting)]TJ /F3 1 Tf 21.5501 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 529.512 393.335 Tm (2)Tj 9.963 0 0 9.963 533.253 395.036 Tm (-)Tj -22.4777 -1.0528 TD [(ago)-8.4(nists,)-227.6(the)-232.7(adminis)-9.1(tration)-230.7(of)-230.8(inhaled)-232.8(corticost)-11.9(eroids)-232.1(and)]TJ 0 -1.0471 TD [(long-)-7.8(actin)-9.4(g)]TJ /F3 1 Tf 4.8484 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 363.175 372.416 Tm (2)Tj 9.963 0 0 9.963 366.916 374.116 Tm [(-agonists)-334.7(in)-334(a)-331.2(fixed)-332.6(combi)-9.7(nation)-334.1(migh)-8.6(t)-327.5(b)0(e)]TJ -5.7816 -1.0528 TD [(con)-8.4(sidered.)-529.5(Thi)-8.8(s)-525.5(may)-529.4(involve)-534(variou)-9(s)-525.5(dosages)-532.1(of)-526.7(the)]TJ 0 -1.0471 TD [(inhal)-9(ed)-383.2(corticost)-11.9(eroid,)-384.2(dependi)-8.5(ng)-382.8(on)-377.1(the)-386.3(severity)-390(of)-378.7(the)]TJ 0 -1.0527 TD [(asthm)-10.9(a.)-229.2(Lab)-6.8(elling)-234.1(these)-241.5(various)-238.5(dosages)-236.2(with)-233.7(vario)-8.2(us)-230.3(co)-7.6(l-)]TJ 0 -1.0471 TD [(ours,)-194(for)-187.6(instance)-189.7(green,)-194.4(orange)-189.1(and)-184.8(red)-192.1(\(comparabl)-11.9(e)-183.3(t)0(o)-186(the)]TJ 0 -1.0527 TD [(colour)-9(s)-343.4(corres)-9.8(pondin)-7(g)-342.2(t)0(o)-345.3(the)-346.5(peak)-345.3(flow)-346.7(ranges)-349.6(in)-345.4(recent)]TJ 0 -1.0471 TD [(self)-8.6(-mana)-9.4(gement)-341(plans\),)-340.6(could)-336.7(be)-337.7(considered.)]TJ 1.0015 -1.0527 TD [(Re)16.1(ce)14.7(nt)18.8(ly)81.4(,)-250.8(i)0(t)-245.3(h)0(a)15.1(s)-246.7(be)15.1(en)-240.9(su)14.4(gg)21.2(es)13.9(te)18.4(d)-251.2(t)0(h)18.8(a)0(t)18.5(,)-250.8(wh)17.3(en)-246.6(a)-251.6(l)0(o)18.8(n)0(g)-240.5(a)0(c)14.7(t)0(i)16.5(n)0(g)]TJ /F3 1 Tf -1.0015 -1.0528 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 314.759 288.737 Tm (2)Tj 9.963 0 0 9.963 318.387 290.381 Tm [(-a)19.2(go)15.5(ni)18.9(st)-352.2(\(f)18(or)19.6(mo)18.1(te)12.8(ro)19.6(l\))-346.9(is)-352.2(us)20(ed)-349.1(on)-348.7(de)20.8(ma)12(nd)21.2(,)-358.9(i)0(t)-347.7(a)0(l)18.4(s)0(o)-349.8(m)0(i)15.7(g)0(h)21.2(t)]TJ -0.9105 -1.0471 TD [(im)15.7(pr)13.9(ov)21.2(e)-274.3(q)0(u)21.2(a)0(l)12.8(i)0(t)22.2(y)-273.9(of)-264.9(li)16.5(fe)-259.6(an)15.1(d)-268.2(a)0(s)14(t)0(h)18.8(m)0(a)-261.2(c)0(o)15.1(n)0(t)18.9(r)0(o)13.9(l)-270.6([2)19.6(1,)-274.3(22].)-283.1(How-)]TJ 0 -1.0528 TD [(eve)-8.8(r)31.8(,)-239.4(this)-242.3(eviden)-7.8(ce)-241.3(is)-244.1(thus)-245.6(far)-244.9(not)-238(sufficient)-247.6(to)-237.2(propos)-7.4(e)-240.2(the)]TJ 0 -1.0471 TD [(intr)-9.4(oduction)-238.9(of)-230.7(long-)-7.8(acting)]TJ /F3 1 Tf 10.8917 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 423.326 257.386 Tm (2)Tj 9.963 0 0 9.963 427.068 259.03 Tm [(-agoni)-9(st)-232.7(even)-231.5(earli)-11(er)-231.2(than)-233.5(in)]TJ -11.8193 -1.0528 TD [(pha)-8.4(se)-333.2(2.)]TJ /F7 1 Tf 0.6601 -3.5509 TD [(The)-336.7(place)-342(of)-333.2(long-a)-7.8(cting)]TJ /F3 1 Tf 10.7551 0 TD (b)Tj /F7 1 Tf 7.472 0 0 6.641 428.598 211.464 Tm (2)Tj 9.963 0 0 9.963 432.34 213.165 Tm [(-adrenergic)-331.5(agon)-8(ists)-333.8(in)]TJ -11.2275 -1.0527 TD [(the)-333.6(treatment)-338.8(of)-333.2(chronic)-331.7(obstruct)-9.7(ive)-335.1(pul)-8.8(monary)]TJ 8.7919 -1.0471 TD [(diseas)-9(e)]TJ /F5 1 Tf -8.9114 -2.7542 TD [(In)-304.7(in)18.9(te)18.4(rn)13.9(at)18.5(io)18.9(na)15.1(l)-310.4(g)0(u)15.5(i)13.9(de)15.1(li)16.5(ne)20.8(s,)-303.9(th)18.9(e)-314.2(p)0(l)18.8(a)0(c)20.4(e)-314.2(of)-304.7(l)13.9(o)0(n)15.5(g)0(-)19.6(a)0(c)14.7(t)0(i)16.5(n)0(g)]TJ /F3 1 Tf 20.5713 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 529.625 163.162 Tm (2)Tj 9.963 0 0 9.963 533.253 164.806 Tm (-)Tj -22.4777 -1.0471 TD [(ad)15.1(re)19.2(ne)15.1(r)20.4(g)0(i)18.9(c)-274.3(ag)15.1(on)21.2(is)17.7(ts)-266.9(in)-265.7(th)18.9(e)-274.3(t)0(r)17.3(e)0(a)14.7(t)0(m)21.4(e)0(n)15.1(t)-276.3(of)-264.9(ch)20.8(ro)13.9(ni)18.9(c)-274.3(o)0(b)21.2(s)0(t)17.7(r)0(u)13.9(c)0(t)18.4(i)0(v)18.9(e)]TJ 0 -1.0528 TD [(pu)15.5(lm)15.7(on)21.2(ar)13.5(y)-273.9(d)0(i)18.9(s)0(e)13.9(a)0(s)19.6(e)-274.3(\(C)14.9(OP)18.1(D\))-268.8(is)-266.9(mu)18.1(ch)-263.7(le)18.4(ss)-271.4(cl)18.5(ea)20.4(r)-275.5(t)0(h)18.8(a)0(n)-269.4(t)0(h)18.9(a)0(t)-266.1(i)0(n)]TJ 0 -1.0471 TD [(th)13.2(e)-251.6(t)0(r)17.3(e)0(a)14.7(t)0(m)15.7(e)0(n)20.8(t)-253.5(of)-247.8(as)19.6(th)18.8(ma)17.7(.)-256.5(I)0(n)-242.1(s)0(e)13.9(v)0(e)20.8(r)0(a)13.5(l)-253.5(gu)21.2(id)13.2(el)18.5(in)18.9(es)-242.1(fo)13.9(r)-252.7(t)0(h)18.9(e)-257.2(tr)17.3(ea)20.4(t-)]TJ 0 -1.0528 TD [(me)12(nt)-220.2(of)-219.4(CO)18.3(PD)12.4(,)-228(t)0(h)18.8(e)-228.8(us)14.4(e)-228.8(o)0(f)-219.4(l)0(o)18.9(n)0(g)15.5(-)0(a)19.2(c)0(t)18.5(i)0(n)13.2(g)]TJ /F3 1 Tf 14.9718 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 463.861 121.323 Tm (2)Tj 9.963 0 0 9.963 467.49 122.967 Tm [(-a)13.5(go)21.2(ni)13.2(st)17.7(s)-229.6(i)0(s)-221.3(s)0(o)20(l)0(e)18.4(l)0(y)]TJ -15.8766 -1.0471 TD [(re)13.5(se)19.6(rv)13.9(ed)-246.6(fo)19.6(r)-258.4(s)0(y)14.4(m)0(p)18.1(t)0(o)18.8(m)0(a)17.7(t)0(i)16.5(c)-262.9(t)13.9(r)0(e)13.5(a)0(t)18.5(m)0(e)17.7(n)0(t)-248.6(o)0(f)-253.5(n)0(o)21.2(c)0(t)18.5(u)0(r)13.9(n)0(a)20.8(l)-259.2(dy)15.5(sp)20(no)15.5(ea)]TJ /F13 1 Tf 10 0 0 10 59.978 212.444 Tm 0 0 0 1 k /GS3 gs (Phase 2)Tj 4.0637 0.39 TD (ICS 200\320400 )Tj /F10 1 Tf 5.015 0 TD (m)Tj /F13 1 Tf 0.576 0 TD (g and long-acting )Tj /F10 1 Tf 6.519 0 TD (b)Tj /F13 1 Tf 8 0 0 8 227.203 213.509 Tm (2)Tj 10 0 0 10 230.851 216.344 Tm (-adrenergic)Tj -13.0237 -1 TD [(agonist with shor)-40(t-acting )]TJ /F10 1 Tf 9.11 0 TD (b)Tj /F13 1 Tf 8 0 0 8 197.204 203.509 Tm (2)Tj 10 0 0 10 200.852 206.344 Tm [(-agonist "if necessar)-30(y")]TJ ET 0 0 0 1 K 0 J 0 j 0.5 w 3.864 M []0 d /GS4 gs 1 i 94.229 226.378 188.395 -25.334 re S 3.864 M 184.78 239.582 m 184.78 231.582 l S 184.78 231.874 m 186.53 231.874 l 184.78 227.499 l 183.03 231.874 l 184.78 231.874 l f* BT 10 0 0 10 59.978 259.445 Tm /GS3 gs (Phase 3)Tj 4.0637 0.7136 TD (ICS 400\320800 )Tj /F10 1 Tf 5.015 0 TD (m)Tj /F13 1 Tf 0.576 0 TD (g and long-acting )Tj /F10 1 Tf 6.519 0 TD (b)Tj /F13 1 Tf 8 0 0 8 227.203 263.746 Tm (2)Tj 10 0 0 10 230.851 266.581 Tm -0.0104 Tc [(-)-10.4(adrenergic)]TJ -13.0237 -1 TD 0 Tc [(agonist, with shor)-40(t-acting )]TJ /F10 1 Tf 9.338 0 TD (b)Tj /F13 1 Tf 8 0 0 8 199.484 253.746 Tm (2)Tj 10 0 0 10 203.132 256.581 Tm (-agonist)Tj -10.2518 -1 TD [("if necessar)-30(y")]TJ ET 3.864 M /GS4 gs 94.229 279.298 188.503 -37.38 re S BT 10 0 0 10 59.978 310.546 Tm /GS3 gs (Phase 4)Tj 4.0468 0.78 TD -0.0104 Tc (ICS >800 )Tj /F10 1 Tf 3.5762 0 TD 0 Tc (m)Tj /F13 1 Tf 0.5655 0 TD -0.0104 Tc (g and long-acting )Tj /F10 1 Tf 6.3314 0 TD 0 Tc (b)Tj /F13 1 Tf 8 0 0 8 210.562 315.512 Tm (2)Tj 10 0 0 10 214.127 318.346 Tm -0.0104 Tc (-adrenergic)Tj -11.3682 -1 TD [(agonist, or)10(al steroids)15(, ipr)10(atropium, with shor)-40(t-acting)]TJ /F10 1 Tf T* 0 Tc (b)Tj /F13 1 Tf 8 0 0 8 105.831 295.512 Tm (2)Tj 10 0 0 10 109.396 298.346 Tm -0.0104 Tc [(-agonist "if necessar)-30(y")]TJ ET /GS4 gs 94.229 328.846 188.503 -34.999 re S 3.864 M 184.78 292.413 m 184.78 284.413 l S 184.78 284.705 m 186.53 284.705 l 184.78 280.33 l 183.03 284.705 l 184.78 284.705 l f* BT 10 0 0 10 59.978 174.574 Tm /GS3 gs 0 Tc (Phase 1)Tj 4.0637 -0.02 TD 0.0035 Tc [(Shor)-40(t-acting )]TJ /F10 1 Tf 4.7348 0 TD 0 Tc (b)Tj /F13 1 Tf 8 0 0 8 153.488 171.54 Tm (2)Tj 10 0 0 10 157.164 174.374 Tm 0.0035 Tc [(-adrenergic agonist "if necessar)-30(y")]TJ ET 3.864 M /GS4 gs 94.229 186.375 188.503 -17 re S 3.864 M 184.78 199.481 m 184.78 191.481 l S 184.78 191.772 m 186.53 191.772 l 184.78 187.397 l 183.03 191.772 l 184.78 191.772 l f* BT /F5 1 Tf 7.97 0 0 7.97 58.28 156.642 Tm 0 g /GS2 gs 0 Tc [(Fig.)-327.1(2.)-331.2(\261)-332.2(Example)-294.5(of)-294.7(a)-302.8(possible)-288.1(future)-302.1(phased)-292.4(plan)-291.7(for)-299.9(the)-300.9(treatment)-291.5(of)]TJ 0 -1.067 TD [(asthma,)-550.1(based)-557.7(on)-550.6(new)-557.1(insights)-547.6(into)-558.3(the)-557(eff)14.1(ects)-555.1(of)-557.9(long-acting)]TJ /F3 1 Tf 27.2504 0 TD (b)Tj /F5 1 Tf 5.977 0 0 5.313 279.893 146.835 Tm (2)Tj 7.97 0 0 7.97 282.841 148.139 Tm (-)Tj -28.1751 -1.0599 TD [(adrener)17.4(gic)-464.5(agonists.)-450.6(The)-457.7(arrows)-459.9(indicate)-456.8(that)-464.8(the)-457.4(medication)-452.8(can)-461.1(be)]TJ T* [(gradually)-332.5(decreased,)-332(if)-339.8(possible.)-329.7(ICS:)-338.1(inhaled)-336.6(corticosteroids)8.1(.)-340.4(Phase)-335(4:)]TJ 0 -1.067 TD [(severe)-284.5(persistent)-285.4(asthma;)-281.1(phase)-287.4(3:)-289.8(moderate)-281.7(persistent)-285.4(asthma;)-281.1(phase)-287.4(2:)]TJ 0 -1.0599 TD [(mild)-331(persistent)-328.1(asthma;)-323.8(phase)-330.1(1:)-332.5(intermittent)-329(asthma.)]TJ 8.966 0 0 8.966 58.28 797.499 Tm (632)Tj 7.472 0 0 7.472 263.792 797.499 Tm 0.0001 Tc [(C.P)102.4(.)-334.1(V)126.3(A)0(N)-331.7(S)0.1(CHA)74.5(YCK)]TJ ET endstream endobj 21 0 obj << /ProcSet [/PDF /Text ] /Font << /F3 6 0 R /F5 8 0 R /F6 9 0 R /F7 10 0 R /F10 12 0 R /F13 13 0 R >> /ExtGState << /GS2 15 0 R /GS3 16 0 R /GS4 17 0 R >> >> endobj 23 0 obj << /Length 20150 >> stream BT /F5 1 Tf 9.963 0 0 9.963 58.28 771.647 Tm 0 g /GS2 gs 0 Tc [([2)19.6(3].)-344.9(The)-348.2(most)-356.9(importan)-10.3(t)-350.3(reason)-355.3(why)-353.3(the)-352.2(place)-354.5(of)-350.2(these)]TJ 0 -1.0471 TD [(agonis)-8.6(ts)-232.7(is)-238.4(not)-238(yet)-238.4(very)-238.4(clear)-242.3(is)-238.4(the)-238.4(lack)-239.6(of)-236.4(well-co)-10.7(ntrolled)]TJ 0 -1.0528 TD [(random)-9.7(ized)-273.7(long-)-7.8(term)-278(trials.)-282.7(Compar)-8.7(ed)-275.1(with)-279.2(short-act)-11.1(ing)]TJ /F3 1 Tf 0 -1.0471 TD 0 Tw (b)Tj /F5 1 Tf 7.472 0 0 6.641 63.78 738.595 Tm (2)Tj 9.963 0 0 9.963 67.521 740.296 Tm [(-agoni)-9(sts)-342.8(and)-338.4(anticholi)-11.5(nergics,)-336.1(the)-340.8(long-)-7.8(acting)-340.2(agonis)-8.6(t)]TJ -0.9276 -1.0528 TD [(has)-231.5(a)-223.1(notabl)-9.7(y)-222.7(stro)-8.2(nger)-227(broncho)-7.3(dila)-8.2(tory)-229(effect)-221.9(in)-225.8(COP)-10.2(D)-226.6(4)0(\261)]TJ 0 -1.0471 TD [(12)-269(h)-273.9(after)-272(admi)-9(nistration)-276.4([24,)-277.4(25].)-271.7(The)-268.6(use)-271.3(of)-276.3(long-acti)-10.7(ng)]TJ 0 -1.0528 TD [(agonis)-8.6(ts)-562.8(may)-563.5(therefore)-567.2(have)-567.2(importan)-10.3(t)-560.8(advant)-7.8(ages)-562.7(in)]TJ 0 -1.0471 TD [(COPD)-9.2(:)-213.7(they)-210.7(can)-219.3(be)-212.5(given)-217.2(twice)-218.2(daily)-213.8(and)-218.9(can)-213.7(also)-217.6(be)-212.5(used)]TJ 0 -1.0527 TD [(to)-214.5(prevent)-215(noctur)-9(nal)-209.9(dyspnoe)-6.9(a)-211.7(\(wh)-7.8(ich)-209.9(is)-215.7(a)-206(maj)-8.2(or)-213.7(symptom)]TJ T* [(in)-402.2(COP)-10.1(D\).)-405.8(As)-405(in)-402.2(asthma,)-410.8(long-)-7.8(acting)]TJ /F3 1 Tf 15.8766 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 221.953 675.836 Tm (2)Tj 9.963 0 0 9.963 225.694 677.48 Tm [(-agoni)-9(sts)-405.4(decr-)]TJ -16.8042 -1.0471 TD [(ease)-409.5(symp)-7.4(toms)-408.1(and)-406.7(improve)-411.2(peak)-407.9(flow)-409.3(in)-407.9(COPD)-413.2([26].)]TJ 0 -1.0528 TD [(Althoug)-8.3(h)-228.4(the)-227(obstructi)-11.5(on)-223.5(often)-230.1(seem)-8.2(s)-223.9(irre)-9(versible)-230.7(\(at)-228.6(least)]TJ 0 -1.0471 TD [(to)-225.8(a)-223.1(lar)10.4(g)-6.5(e)-223.1(extent\))-228.7(and)-224.6(there)-8.6(fore)-222.9(leaves)-231.3(little)-227.4(room)-229.7(for)-227.4(abso-)]TJ 0 -1.0527 TD [(lute)-406.6(imp)-7.8(rovement)-412.4(in)-402.2(the)-403.4(obstr)-9(uction)-408.1(in)-402.3(COPD)-413.2(patients,)]TJ 0 -1.0471 TD [(the)-352.2(use)-356.7(of)-355.9(long-acti)-10.7(ng)-348.7(agon)-9.1(ists)-351.6(has)-356.7(proved)-359.4(to)-351(produce)-360.6(a)]TJ 0 -1.0527 TD [(decreas)-9.7(e)-422.3(i)0(n)-419.3(dyspnoe)-6.9(a)-422.3([27])-421.6(and)-423.8(a)-422.3(clear)-424.4(imp)-7.8(rovemen)-10.9(t)-418.6(i)0(n)]TJ 0 -1.0471 TD [(quality)-303.1(of)-293.3(lif)-8.6(e)-291.4([28].)-302.5(There)-300.6(are)-294.9(indi)-7.8(cations)-302.3(that)-298.4(the)-295.3(c)-6.9(hange)]TJ 0 -1.0528 TD [(in)-316.9(lung)-312.7(funct)-8.2(ion)-317.7(in)-311.2(COP)-10.1(D)-312(patien)-10.1(ts)-312.4(\(mea)-8.6(sured)-314.3(as)-316.1(the)-318.1(for-)]TJ 0 -1.0471 TD [(ced)-503.9(expir)-8.2(atory)-503.3(volum)-9.3(e)-501.9(i)0(n)-499(one)-503.5(second)-507.3(\(FE)-7.2(V)]TJ 7.97 0 0 7.97 243.723 583.37 Tm (1)Tj 9.963 0 0 9.963 247.691 583.37 Tm [(\)\))-505.5(is)-500.2(less)]TJ -19.0121 -1.0527 TD [(relev)-8.6(ant)-306.7(than)-307.4(that)-309.8(in)-305.5(airway)-309.2(resi)-8.6(stance)-305.3(a)-6.9(n)0(d)-303.1(work)-310.2(of)-304.7(brea-)]TJ 0 -1.0471 TD [(thing.)-384.5(The)-376.7(latter)-384(tw)-7.8(o)-376.3(variables)-385.5(imp)-7.8(rove)-380.6(during)-378.4(u)-6.5(s)0(e)-378.7(o)0(f)-378.7(a)]TJ 0 -1.0528 TD [(long-)-7.8(acting)]TJ /F3 1 Tf 4.9508 0 TD (b)Tj /F5 1 Tf 7.472 0 0 6.641 113.102 550.318 Tm (2)Tj 9.963 0 0 9.963 116.844 551.962 Tm [(-agonist)-435.2(wi)-7.8(thout)-429.7(there)-435.4(being)-439.1(any)-429.5(eviden)-7.8(t)]TJ -5.8783 -1.0471 TD [(improvem)-11.1(ent)-437.6(in)-436.4(the)-437.6(FEV)]TJ 7.97 0 0 7.97 162.425 541.531 Tm (1)Tj 9.963 0 0 9.963 170.702 541.531 Tm [([29].)-439.1(Moreo)-7.8(ver)24.2(,)-432.9(i)0(t)-433.1(has)-442.1(been)]TJ -11.2844 -1.0527 TD [(demon)-7.4(strated)-321(that,)-315.9(after)-317.5(use)-316.9(of)-310.4(a)-314.2(long-)-7.8(acting)-317.4(agonis)-8.6(t,)-310.8(the)]TJ 0 -1.0471 TD [(walking)-304.7(distance)-309.2(achieved)-300.3(du)-7.2(ring)-297.2(the)-301(6-min)-301.2(wal)-9(king)-295.7(test)]TJ 0 -1.0528 TD [(improved)-269.7(signifi)-9.6(cantly)58.1(,)-256.5(wher)-9(eas)-260.4(there)-264.7(was)-258.2(no)-263.3(eviden)-7.8(t)-253.5(im-)]TJ 0 -1.0471 TD [(provem)-9.7(ent)-266.8(in)-260(the)-266.8(FEV)]TJ 7.97 0 0 7.97 146.891 499.691 Tm (1)Tj 9.963 0 0 9.963 153.524 499.691 Tm [([30].)-262.7(The)-268.6(FEV)]TJ 7.97 0 0 7.97 211.748 499.691 Tm (1)Tj 9.963 0 0 9.963 218.324 499.691 Tm [(may)-267.6(there)-8.6(fore)-268.4(be)]TJ -16.0644 -1.0527 TD [(a)-319.8(less)-321.2(suitable)-328.2(parameter)-330.2(for)-318.5(evalua)-8.2(ting)-320.8(the)-318.1(e)-6.9(f)0(f)12.4(ecti)-8.6(veness)]TJ 0 -1.0471 TD [(of)-264.9(broncho)-7.3(dila)-8.2(tors)-270(in)-265.7(COPD)-9.2(.)-262.1(For)-270.6(COPD)-270.9(patients,)-271.7(the)-266.8(im-)]TJ 0 -1.0528 TD [(provem)-9.7(ents)-382.6(in)-373.8(wor)-7.8(k)-376.3(o)0(f)-378.7(breat)-8.6(hing,)-381.4(walking)-384.3(distance)-388.8(and)]TJ 0 -1.0471 TD [(quality)-342.9(of)-333.2(life)-339.9(are,)-335.1(of)-338.9(course)-8.2(,)-330.4(o)0(f)-338.9(great)-338.6(importan)-10.3(ce.)]TJ 1.0015 -1.0528 TD [(It)-307.1(is)-306.7(no)21.2(t)-316.1(y)0(e)15.1(t)-310.4(cl)12.8(ea)20.4(r)-315.3(w)0(h)17.3(a)0(t)-305.9(w)0(i)14.9(l)0(l)-302.2(b)0(e)-309.2(t)0(h)18.9(e)-314.2(pl)18.9(ac)14.7(e)-314.2(o)0(f)-304.7(l)0(o)18.9(n)0(g)15.5(-)0(a)19.2(c)0(t)18.4(i)0(n)13.2(g)]TJ -1.0015 -1.0471 TD [(an)15.1(ti)22.2(ch)15.1(ol)18.9(in)18.8(er)24.9(gi)18.9(cs)-247.8(fo)19.6(r)-252.7(c)0(h)15.1(r)0(o)19.6(n)0(i)18.9(c)-251.6(ob)15.5(st)17.7(ru)19.6(ct)12.8(i)13.9(v)0(e)-246.6(p)0(u)15.5(l)0(m)21.4(o)0(n)15.5(a)0(r)19.2(y)-256.8(di)18.9(se)19.6(as)13.9(e)]TJ 0 -1.0527 TD [(pa)15.1(ti)22.2(en)15.1(ts)17.7(.)-563.7(I)0(n)19.6(i)0(t)16.5(i)0(a)18.4(l)-566.5(ex)15.1(pe)20.8(ri)17.3(en)15.1(ce)-554.3(wi)14.9(th)-550.2(lo)13.2(ng)21.2(-a)13.5(ct)18.4(in)18.9(g)-564.1(t)0(i)16.5(o)0(t)18.9(r)0(o)19.6(p)0(i)13.2(u)0(m)]TJ 0 -1.0471 TD [(br)19.6(om)12.4(id)18.9(e)-257.2(i)0(n)-248.6(c)0(h)20.8(r)0(o)19.6(n)0(i)13.2(c)-257.2(ob)21.2(st)17.7(ru)13.9(ct)18.5(iv)18.9(e)-257.2(p)0(u)21.2(l)0(m)15.7(o)0(n)15.5(a)0(r)19.2(y)-256.8(di)18.9(se)13.9(as)19.6(e)-257.2(p)0(a)20.8(t)0(i)16.5(e)0(n)15.1(t)0(s)]TJ 0 -1.0527 TD [(is)-318.1(pr)19.6(om)18.1(is)17.7(in)18.9(g)-325.1([)0(3)13.9(1)0(,)-319.8(32].)]TJ /F7 1 Tf 8.966 0 0 8.966 151.257 368.561 Tm [(Referenc)8.7(es)]TJ /F5 1 Tf -10.3696 -2.9971 TD [(1.)-1766.5(Miller)-372.2(BD,)-370.3(Strunck)-377.5(RC.)-371.7(Circumstances)-373.9(surrounding)-379.3(the)]TJ 2.5165 -1.1128 TD [(deaths)-385.8(of)-385.7(children)-386.9(due)-384(to)-387.1(asthma.)-390.5(A)-382.2(case-control)-392.9(study)62.2(.)]TJ /F6 1 Tf T* [(Am)-328.2(J)-334.4(Dis)-334.1(Child)]TJ /F5 1 Tf 6.6707 0 TD [(1989;)-334.9(143:)-335.5(1294\2611299.)]TJ -9.1872 -1.1128 TD [(2.)-1766.5(Crane)-255.6(J,)-256.5(Pearce)-261.1(N,)-252.3(Flatt)-262.2(A,)]TJ /F6 1 Tf 13.4172 0 TD [(et)-254.1(al)]TJ /F5 1 Tf 1.7325 0 TD [(.)-255.8(Prescribed)-257.5(fenoterol)-260.9(and)]TJ -12.6332 -1.1065 TD [(death)-328.2(from)-336.9(asthma)-337.1(in)-330.2(New)-333.6(Zealand,)-333.3(1981\26183:)-333.4(case-con-)]TJ 0 -1.1128 TD [(trol)-332.5(study)62.2(.)]TJ /F6 1 Tf 4.3691 0 TD (Lancet)Tj /F5 1 Tf 3.035 0 TD [(1989;)-328.6(i:)-338.9(917\261922.)]TJ -9.9206 -1.1128 TD [(3.)-1766.5(Pearce)-438.2(N,)-442(Grainger)-445.7(J,)-439.9(Atkinson)-441.5(M,)]TJ /F6 1 Tf 17.6725 0 TD [(et)-443.7(al)]TJ /F5 1 Tf 1.9222 0 TD [(.)-439.2(Case-control)]TJ -17.0782 -1.1128 TD [(study)-386.7(of)-385.7(prescribed)-391.7(fenoterol)-387.3(and)-390.3(death)-385.1(from)-387.5(asthma)-394(in)]TJ 0 -1.1065 TD [(New)-333.6(Zealand,)-333.3(1977-81.)]TJ /F6 1 Tf 9.8827 0 TD (Thorax)Tj /F5 1 Tf 3.2057 0 TD [(1990;)-334.9(45:)-329.6(170\261175.)]TJ -15.6049 -1.1128 TD [(4.)-1766.5(Grainger)-521.5(J,)-515.8(W)70.8(oodman)-517.1(K,)-517.9(Pearce)-520.4(N,)]TJ /F6 1 Tf 18.3997 0 TD [(et)-519.6(al)]TJ /F5 1 Tf 1.998 0 TD [(.)-521.4(Prescribed)]TJ -17.8812 -1.1128 TD [(fenoterol)-298.8(and)-295.4(death)-296.6(from)-299(asthma)-305.4(in)-292.2(New)-302(Zealand,)-295.4(1981\261)]TJ 0 -1.1065 TD [(87:)-146.3(a)-144.7(further)-146.9(case-control)-152.6(study)62.2(.)]TJ /F6 1 Tf 12.2791 0 TD (Thorax)Tj /F5 1 Tf 3.016 0 TD [(1991;)-151.6(46:)-146.3(105\2611)34.2(1)32.1(1)0(.)]TJ -17.8116 -1.1128 TD [(5.)-1766.5(Spitzer)-417.6(WO,)-421.8(Suissa)-423.7(S,)-418.3(Ernst)-422.8(P)103.1(,)]TJ /F6 1 Tf 15.8452 0 TD [(et)-424.8(al)]TJ /F5 1 Tf 1.9032 0 TD [(.)-420.2(The)-419(use)-423.1(of)-417.3(beta-)]TJ -15.2319 -1.1128 TD [(agonists)-224.1(and)-219.6(the)-228.3(risk)-223.8(of)-221.3(death)-227(and)-219.6(near)-226.1(death)-227(from)-223.1(asthma.)]TJ /F6 1 Tf T* [(N)-333(Engl)-332.6(J)-334.4(Med)]TJ /F5 1 Tf 6.07 0 TD [(1992;)-328.6(326:)-335.5(501\261506.)]TJ -8.5865 -1.1065 TD [(6.)-1766.5(Mullen)-286.7(M,)-287.6(Mullen)-293(B,)-285.3(Carey)-293.5(M.)-287.6(The)-286.3(association)-294.1(between)]TJ 2.5165 -1.1128 TD [(beta-agonists)-237.1(use)-233.4(and)-238.5(death)-233.3(from)-242.1(asthma.)-238.8(A)-230.4(meta-analytic)]TJ T* [(integration)-567.2(of)-562.7(case-control)-569.9(studies.)]TJ /F6 1 Tf 15.1813 0 TD (JAMA)Tj /F5 1 Tf 3.0287 0 TD [(1993;)-568.9(270:)]TJ -18.21 -1.1128 TD (1842\2611845.)Tj -2.5165 -1.1065 TD [(7.)-1766.5(Sears)-370.8(MR,)-374(T)66.6(aylor)-373.6(DR,)-376.6(Print)-374.8(CG,)]TJ /F6 1 Tf 16.4396 0 TD [(et)-374.2(al)]TJ /F5 1 Tf 1.8526 0 TD [(.)-369.6(Regular)-370.8(inhaled)]TJ -15.7757 -1.1128 TD [(beta-agonist)-293.3(treatment)-295.6(in)-285.9(bronchial)-297.9(asthma.)]TJ /F6 1 Tf 17.5587 0 TD (Lancet)Tj /F5 1 Tf 2.9907 0 TD (1990;)Tj -20.5495 -1.1128 TD [(336:)-329.1(1391\2611396.)]TJ -2.5165 -1.1065 TD [(8.)-1766.5(V)104.7(a)0(n)-251.7(Schayck)-247.3(CP)105.2(,)-249.5(Dompeling)-258(E,)-246.2(van)-251.2(Herwaarden)-255.4(CLA,)]TJ /F6 1 Tf 24.6277 0 TD (et)Tj -22.1112 -1.1128 TD (al)Tj /F5 1 Tf 0.7651 0 TD [(.)-350.7(Bronchodilator)-353.9(treatment)-352.5(in)-349.1(moderate)-354.5(asthma)-349.7(or)-347.7(chr-)]TJ 27.2328 73.5671 TD [(onic)-253(bronchitis:)-258.8(continuous)-253.5(or)-252.9(on)-251.9(demand?)-256.9(A)-255.7(randomised)]TJ 0 -1.1191 TD [(controlled)-337.7(study)62.2(.)]TJ /F6 1 Tf 7.0184 0 TD (BMJ)Tj /F5 1 Tf 2.2004 0 TD [(1991;)-328.6(303:)-335.5(1426\2611431.)]TJ -11.7353 -1.1065 TD [(9.)-1766.5(T)60.2(own)-463.4(GI,)-467.7(O)]TJ /F17 1 Tf 7.7203 0 TD (')Tj /F5 1 Tf 0.215 0 TD [(Donnell)-472.2(TV)127(,)-464.5(Purdie)-466.5(G.)-467.3(Bronchial)-473.3(respon-)]TJ -5.4187 -1.1192 TD [(siveness)-463(during)-461.9(regular)-461.9(fenoterol)-463.2(therapy:)-462.8(four)-461.5(months)]TJ 0 -1.1128 TD [(prospective)-335.7(study)62.2(.)]TJ /F6 1 Tf 7.5685 0 TD [(N)-333(Z)-333.2(Med)-333.8(J)]TJ /F5 1 Tf 4.7485 0 TD [(1991;)-334.9(104:)-335.5(3\2615.)]TJ -14.8335 -1.1128 TD [(10.)-1266.5(Booth)-744.3(H,)-751.8(Fishwick)-749.6(K,)-745.5(Harkawat)-751.3(R,)-746.9(Devereux)-751.9(G,)]TJ 2.5165 -1.1128 TD [(Hendrick)-375.2(DJ,)-366.8(W)70.8(alters)-376.5(EH.)-369.1(Changes)-374.9(in)-368.1(methacholine)-375(in-)]TJ 0 -1.1192 TD [(duced)-534.5(bronchoconstriction)-546(with)-537.2(the)-538.1(long)-537.8(acting)-538.7(beta2)]TJ 0 -1.1128 TD [(agonist)-248.8(salmeterol)-252(in)-241.7(mild)-251.2(to)-248(moderate)-247.1(asthmatic)-251.5(patients.)]TJ /F6 1 Tf 0 -1.1191 TD (Thorax)Tj /F5 1 Tf 3.2057 0 TD [(1993;)-334.9(48:)-336(1)32.1(121\2611)34.2(124.)]TJ -5.7222 -1.1128 TD [(1)25.8(1)0(.)-1292.3(V)104.7(an)-251.7(Schayck)-247.3(CP)98.9(,)-249.5(Dompeling)-251.7(E,)-252.5(van)-251.2(Herwaarden)-249.1(CLA,)]TJ /F6 1 Tf 24.6277 0 TD (et)Tj -22.1112 -1.1128 TD (al)Tj /F5 1 Tf 0.7714 0 TD [(.)-312.7(Continuous)-309.1(and)-314.4(on)-308.8(demand)-314.5(use)-309.3(of)-316.1(bronchodilators)-312(in)]TJ -0.7714 -1.1128 TD [(patients)-370.5(with)-366.4(non-steroid)-362.5(dependant)-370.2(asthma)-368.7(and)-365(chronic)]TJ 0 -1.1191 TD [(bronchitis:)-537(four)-531(year)-535.9(follow-up)-530.2(randomized)-536.9(controlled)]TJ 0 -1.1128 TD [(study)62.2(.)]TJ /F6 1 Tf 2.6746 0 TD [(Br)-332.5(J)-334.4(Gen)-336.7(Pract)]TJ /F5 1 Tf 6.6138 0 TD [(1995;)-334.9(45:)-329.7(239\261244.)]TJ -11.8049 -1.1128 TD [(12.)-1266.5(V)104.7(a)0(n)-213.7(der)-220.5(Molen)-215.3(T)72.9(,)-211.6(Postma)-222(DS,)-212.4(T)28.6(urner)-214.1(MO,)]TJ /F6 1 Tf 19.3671 0 TD [(et)-216.1(al)]TJ /F5 1 Tf 1.6945 0 TD [(.)-217.9(Effec)10.2(ts)-217.6(of)]TJ -18.5451 -1.1192 TD [(the)-259.9(long)-265.9(acting)-260.5(beta)-265.5(agonist)-261.4(formoterol)-269.8(on)-258.2(asthma)-267.5(control)]TJ 0 -1.1128 TD [(in)-418.7(asthmatic)-428.6(patients)-421.1(using)-418.3(inhaled)-424.4(corticosteroids.)-425.7(The)]TJ 0 -1.1192 TD [(Netherlands)-433.9(and)-421.9(Canadian)-432.3(Formoterol)-431.8(Study)-428.4(Investiga-)]TJ 0 -1.1128 TD (tors.)Tj /F6 1 Tf 2.0613 0 TD (Thorax)Tj /F5 1 Tf 3.2057 0 TD [(1997;)-334.9(52:)-336(535\261539.)]TJ -7.7835 -1.1128 TD [(13.)-1266.5(V)104.7(a)0(n)-270.7(Schayck)-266.2(CP)105.2(,)-268.5(Graafsma)-269.1(SJ,)-267.2(V)47.8(isch)-266.9(MB,)-266.5(Dompeling)-270.7(E,)]TJ 2.5165 -1.1128 TD [(van)-346(W)70.8(eel)-348.2(C,)-348.6(van)-346(Herwaarden)-350.3(CLA.)-348(Increased)-351.7(bronchial)]TJ 0 -1.1192 TD [(hyperresponsiveness)-428.4(after)-431.3(inhaling)-432.8(salbutamol)-428.3(during)-430.3(1)]TJ 0 -1.1128 TD [(year)-422.1(is)-426.2(not)-418.2(caused)-427.4(by)-422.6(subsensitization)-424(to)-425(salbutamol.)]TJ /F6 1 Tf 22.3831 0 TD (J)Tj -22.3831 -1.1192 TD [(Aller)31.3(gy)-333.9(Clin)-336.2(Immunol)]TJ /F5 1 Tf 9.1113 0 TD [(1990;)-334.9(86:)-329.7(793\261800.)]TJ -11.6278 -1.1065 TD [(14.)-1266.5(Cheung)-532.6(D,)-530.5(T)28.6(immers)-529.8(MC,)-532.1(Zwinderman)-537.6(AH,)-533.3(Bel)-530.2(EH,)]TJ 2.5165 -1.1191 TD [(Dijkman)-265.4(JH,)-271.9(Sterk)-264.7(PJ.)-267.2(Long-term)-270.4(ef)12.9(fects)-267.1(of)-271.8(a)-264.8(long-acting)]TJ 0 -1.1128 TD [(beta2-adrenoceptor)-294.3(agonist,)-295.9(salmeterol,)-299.2(on)-289.8(airway)-294(hyper-)]TJ 0 -1.1192 TD [(responsiveness)-430.2(in)-431.3(patients)-433.8(with)-429.7(mild)-428.2(asthma.)]TJ /F6 1 Tf 18.9814 0 TD [(N)-434.2(Engl)-427.5(J)]TJ -18.9814 -1.1128 TD (Med)Tj /F5 1 Tf 2.0929 0 TD [(1992;)-334.9(327:)-329.1(1)25.8(198\2611203.)]TJ -4.6094 -1.1128 TD [(15.)-1266.5(Arvidsson)-662(P)103.1(,)-660.5(Larsson)-660.6(S,)-664.9(Lofdahl)-660.6(CG,)-661.2(Melander)-663.2(B,)]TJ 2.5165 -1.1128 TD [(Svedmyr)-275.8(N,)-277.6(W)70.8(ahlander)-276.8(L.)-271.5(Inhaled)-277.5(formoterol)-282.4(during)-278.5(one)]TJ 0 -1.1192 TD [(year)-226.1(in)-222.7(asthma:)-231.4(a)-220.6(comparison)-228.5(with)-227.3(salbutamol.)]TJ /F6 1 Tf 18.5261 0 TD [(Eur)-224.5(Respir)]TJ -18.5261 -1.1128 TD (J)Tj /F5 1 Tf 0.7714 0 TD [(1991;)-334.9(4:)-330.2(1)32.1(168\2611)27.8(173.)]TJ -3.2879 -1.1128 TD [(16.)-1266.5(W)70.8(orld)-323.8(Health)-327(Organisation/National)-323.6(Institutes)-330(of)-328.8(Health.)]TJ 2.5165 -1.1192 TD [(Global)-687.6(Initiative)-690.2(for)-689.6(Asthma.)-684.9(Bethesda,)-689.3(MD,)-688.7(USA,)]TJ 0 -1.1128 TD [(National)-334.7(Institutes)-336.3(of)-335.1(Health,)-336.2(1995.)]TJ -2.5165 -1.1128 TD [(17.)-1266.5(National)-416.9(Heart,)-417.5(Lung)-412.4(and)-409.2(Blood)-415.5(Institute.)-420.8(International)]TJ 2.5165 -1.1128 TD [(consensus)-377.9(report)-386.7(on)-378.4(diagnosis)-381.7(and)-377.6(treatment)-384.1(of)-379.3(asthma.)]TJ /F6 1 Tf 0 -1.1192 TD [(Eur)-332(Respir)-333.8(J)]TJ /F5 1 Tf 5.5073 0 TD [(1992;)-334.9(5:)-330.2(601\261641.)]TJ -8.0238 -1.1065 TD [(18.)-1266.5(Greening)-457.4(AP)100.3(,)-458.2(Ind)-454.7(PW)85.3(,)-458.2(Northfield)-462.3(M,)-458.3(Shaw)-461.2(G.)-454.6(Added)]TJ 2.5165 -1.1192 TD (salmeterol)Tj /F6 1 Tf 4.3122 0 TD (versus)Tj /F5 1 Tf 2.7441 0 TD [(higher)12.6(-dose)-214.4(corticosteroid)-213.5(in)-210(asthma)-216.9(pa-)]TJ -7.0564 -1.1128 TD [(tients)-352.8(with)-353.8(symptoms)-358.5(on)-353.1(existing)-351.8(inhaled)-354.8(corticosteroid.)]TJ 0 -1.1192 TD [(Allen)-517.4(&)-519.9(Hanburys)-513.3(Limited)-520.9(UK)-517.7(Study)-516.9(Group.)]TJ /F6 1 Tf 20.1195 0 TD (Lancet)Tj /F5 1 Tf -20.1195 -1.1128 TD [(1994;)-334.9(344:)-329.1(219\261224.)]TJ -2.5165 -1.1128 TD [(19.)-1266.5(W)70.8(oolcock)-238.6(A,)-239.6(Lundback)-239.2(B,)-241.1(Ringdal)-239.6(N,)-246(Jacques)-238.4(LA.)-242.6(Com-)]TJ 2.5165 -1.1128 TD [(parison)-297.9(of)-303.5(addition)-300(of)-297.1(salmeterol)-302.6(to)-298.6(inhaled)-304.3(steroids)-301(with)]TJ 0 -1.1192 TD [(doubling)-241(of)-246.5(the)-240.9(dose)-245.5(of)-246.5(inhaled)-241(steroids.)]TJ /F6 1 Tf 16.155 0 TD [(Am)-246(J)-239.6(Respir)-245.2(Crit)]TJ -16.155 -1.1128 TD [(Car)33.6(e)-334.4(Med)]TJ /F5 1 Tf 4.3818 0 TD [(1996;)-334.9(153:)-335.5(1481\2611488.)]TJ -6.8983 -1.1128 TD [(20.)-1266.5(Pauwels)-418.7(RA,)-414.6(Lofdahl)-420.3(CG,)-414.6(Postma)-418.1(DS,)]TJ /F6 1 Tf 19.1521 0 TD [(et)-418.5(al)]TJ /F5 1 Tf 1.8969 0 TD [(.)-413.9(Effec)10.2(t)-419.2(o)0(f)]TJ -18.5325 -1.1192 TD [(inhaled)-411.7(formoterol)-415.2(and)-409.2(budesonide)-409(on)-410(exacerbations)-416.5(of)]TJ 0 -1.1128 TD [(asthma.)-738.3(Formoterol)-741.6(and)-738(Corticosteroids)-743.9(Establishing)]TJ T* [(Therapy)-379.8(\(F)71(ACET\))-386.4(International)-383.5(Study)-384.1(Group.)]TJ /F6 1 Tf 19.0762 0 TD [(N)-383.6(Engl)-383.2(J)]TJ -19.0762 -1.1192 TD (Med)Tj /F5 1 Tf 2.0929 0 TD [(1997;)-334.9(337:)-329.1(1405\261141)29.4(1.)]TJ -4.6094 -1.1128 TD [(21.)-1266.5(T)60.2(attersfield)-234(A,)-233.3(Lofdahl)-230.7(CG,)-237.5(Postma)-228.4(DS,)]TJ /F6 1 Tf 18.5514 0 TD [(et)-228.8(al)]TJ /F5 1 Tf 1.7072 0 TD [(.)-230.5(O)0(n)-236.2(demand)]TJ -17.7421 -1.1128 TD [(treatment:)-461.8(comparison)-462.4(of)-448.9(formoterol)-465.8(and)-459.8(terbutaline)-459.5(in)]TJ 0 -1.1192 TD [(moderate)-266(asthma.)]TJ /F6 1 Tf 7.2587 0 TD [(Am)-271.4(J)-264.8(Respir)-264.2(Crit)-274.2(Car)33.6(e)-264.8(Med)]TJ /F5 1 Tf 11.2548 0 TD [(1999;)-265.4(159:)]TJ -18.5135 -1.1128 TD (A636.)Tj -2.5165 -1.1128 TD [(22.)-1266.5(Postma)-253.7(DS,)-250.4(Lofdahl)-249.6(CG,)-250.2(T)60.2(attersfield)-253(A,)]TJ /F6 1 Tf 18.6589 0 TD [(et)-254.1(al)]TJ /F5 1 Tf 1.7325 0 TD [(.)-249.5(Formoterol)]TJ -17.8749 -1.1128 TD [(used)-296.1(on)-302.5(demand)-295.5(improves)-305.6(quality)-300.5(of)-297.1(life)-300.7(in)-304.9(patients)-301(with)]TJ 0 -1.1192 TD (asthma.)Tj /F6 1 Tf 3.3828 0 TD [(Am)-334.6(J)-334.4(Respir)-333.8(Crit)-337.4(Car)33.6(e)-334.4(Med)]TJ /F5 1 Tf 11.6531 0 TD [(1999;)-334.9(159:)-335.5(A760.)]TJ -17.5524 -1.1065 TD [(23.)-1266.5(Anonymous.)-352.4(British)-351.9(Thoracic)-356.2(Society)-353.4(guidelines)-350.6(for)-354.5(the)]TJ 2.5165 -1.1192 TD [(management)-436.4(of)-436.2(chronic)-435.6(obstructive)-433.2(pulmonary)-436.7(disease.)]TJ /F6 1 Tf 0 -1.1128 TD (Thorax)Tj /F5 1 Tf 3.2057 0 TD [(1997;)-334.9(52:)-336(S1\261S28.)]TJ -5.7222 -1.1128 TD [(24.)-1266.5(Cazzola)-287.2(M,)-281.3(Santangelo)-288.4(G,)-283.9(Piccolo)-283.9(A,)]TJ /F6 1 Tf 17.8496 0 TD [(et)-285.7(al)]TJ /F5 1 Tf 1.7641 0 TD [(.)-281.1(Effec)10.2(t)-286.4(o)0(f)-284.5(sal-)]TJ -17.0971 -1.1192 TD [(meterol)-300.8(and)-295.4(formoterol)-301.4(in)-298.6(patients)-294.7(with)-303.2(chronic)-296.5(obstruct-)]TJ 0 -1.1128 TD [(ive)-127.1(pulmonary)-133.2(disease.)]TJ /F6 1 Tf 9.0038 0 TD [(Pulm)-127.3(Pharmacol)]TJ /F5 1 Tf 6.7655 0 TD [(1994;)-132.6(7:)-127.8(103\261107.)]TJ 5.5515 76.3934 TD (633)Tj /F3 1 Tf 6.974 0 0 6.974 186.009 797.499 Tm (b)Tj /F5 1 Tf 5.604 0 0 4.98 189.865 796.252 Tm (2)Tj 7.472 0 0 7.472 195.137 797.499 Tm 0.0001 Tc [(AGONISTS)-340.5(IN)-333.2(ASTH)-10.3(MA)-331.6(AND)-342.1(COPD)-335.2(TREA)103.6(TME)-8.5(NT)-331.9(GUIDELINE)-13.1(S)]TJ ET endstream endobj 24 0 obj << /ProcSet [/PDF /Text ] /Font << /F3 6 0 R /F5 8 0 R /F6 9 0 R /F7 10 0 R /F17 25 0 R >> /ExtGState << /GS2 15 0 R >> >> endobj 27 0 obj << /Length 4566 >> stream BT /F5 1 Tf 8.966 0 0 8.966 58.28 772.157 Tm 0 g /GS2 gs 0 Tc [(25.)-1266.5(Matera)-721.1(MG,)-720.4(Cazzola)-723.4(M,)-723.9(V)54.1(inciquerra)-728.1(A,)]TJ /F6 1 Tf 21.441 0 TD [(et)-722(al)]TJ /F5 1 Tf 2.2004 0 TD 0.7237 Tc (.A)Tj -21.1248 -1.1128 TD 0 Tc [(comparison)-348.6(of)-354(the)-354.7(bronchodilating)-350.1(effects)-349(of)-347.7(salmeterol,)]TJ T* [(salbutamol)-580(and)-580(ipratropium)-580.5(bromide)-583.1(in)-576.8(patients)-579.2(with)]TJ 0 -1.1065 TD [(chronic)-309.2(obstructive)-313.1(pulmonary)-310.2(disease.)]TJ /F6 1 Tf 15.997 0 TD [(Pulm)-310.6(Pharmacol)]TJ /F5 1 Tf -15.997 -1.1128 TD [(1995;)-328.6(8:)-336.5(267\261271.)]TJ -2.5165 -1.1128 TD [(26.)-1266.5(Ulrik)-341.6(CS.)-340.3(Efficac)9.1(y)-340.9(o)0(f)-341.4(inhaled)-342.2(salmeterol)-346.8(in)-336.5(the)-342.1(manage-)]TJ 2.5165 -1.1065 TD [(ment)-545.8(of)-550(smokers)-551.5(with)-549.8(chronic)-549.4(obstructive)-553.3(pulmonary)]TJ 0 -1.1128 TD [(disease:)-217.4(a)-220.6(single)-224(centre)-220.9(randomised,)-218.7(double)-220.4(blind,)-220.1(placebo)]TJ T* [(controlled,)-334.3(crossover)-334.4(study)62.2(.)]TJ /F6 1 Tf 11.3876 0 TD (Thorax)Tj /F5 1 Tf 3.212 0 TD [(1995;)-328.6(50:)-336(750\261754.)]TJ -17.1161 -1.1128 TD [(27.)-1266.5(Ramirez-V)104.9(enegas)-541.2(A,)-543.1(W)77.1(ard)-543(J,)-541(Lentine)-541.7(T)72.9(,)-534(Mahler)-544.3(DA.)]TJ 2.5165 -1.1065 TD [(Salmeterol)-262(reduces)-269.8(dyspnoea)-262.2(and)-257.5(improves)-267.7(lung)-265.9(function)]TJ 0 -1.1128 TD [(in)-330.2(patients)-338.9(with)-334.8(COPD.)]TJ /F6 1 Tf 9.8384 0 TD (Chest)Tj /F5 1 Tf 2.5924 0 TD [(1997;)-334.9(1)32.1(12:)-329.6(336\261340.)]TJ -14.9474 -1.1128 TD [(28.)-1266.5(Jones)-353.7(PW)85.3(,)-350.7(Bosch)-357.2(TK.)-350.1(Quality)-360.7(of)-354(life)-351.2(changes)-357.3(in)-355.5(COPD)]TJ 2.5165 -1.1128 TD [(patients)-383.2(treated)-387.2(with)-385.4(salmeterol.)]TJ /F6 1 Tf 13.3919 0 TD [(Am)-385.2(J)-378.7(Respir)-384.3(Crit)-388(Car)33.6(e)]TJ -13.3919 -1.1065 TD (Med)Tj /F5 1 Tf 2.0929 0 TD [(1997;)-328.6(155:)-335.5(1283\2611289.)]TJ -4.6094 -1.1128 TD [(29.)-1266.5(Maesen)-390.2(BLP)102.2(,)-394.9(W)77.1(estermann)-399.5(CJJ,)-394.2(Duurkens)-393.2(V)123.6(AM,)-391.6(Bosch)]TJ 30.5144 16.6672 TD [(JMM.)-497.1(Formoterol)-501.3(induced)-497.9(responses)-505.3(in)-494.6(non-reversible)]TJ 0 -1.1128 TD [(chronic)-302.8(obstructive)-306.7(pulmonary)-303.9(disease.)]TJ /F6 1 Tf 15.978 0 TD [(Am)-303(J)-302.8(Respir)-302.1(Crit)]TJ -15.978 -1.1128 TD [(Car)33.6(e)-334.4(Med)]TJ /F5 1 Tf 4.3818 0 TD [(1997;)-334.9(155:)-335.5(A282.)]TJ -6.8983 -1.1065 TD [(30.)-1266.5(T)28.6(utluoglu)-325.5(B,)-329.6(Gurbuz)-329.8(N,)-328.2(Sahin)-327(S,)-329.8(Abanoziu)-329.9(S,)-323.5(Ozden)-329.1(S.)]TJ 2.5165 -1.1128 TD [(Effec)10.2(ts)-363(of)-360.4(short)-368.7(term)-363.4(usage)-358.6(of)-354(formoterol)-364.6(on)-359.4(six)-362.5(minute)]TJ T* [(walking)-383.6(test)-389.4(in)-387.1(COPD)-380.9(patients.)]TJ /F6 1 Tf 13.2339 0 TD [(Eur)-382.5(Respir)-384.3(J)]TJ /F5 1 Tf 5.659 0 TD [(1997;)-385.5(10:)]TJ -18.8929 -1.1065 TD [(Suppl.)-330.1(25,)-337(65s.)]TJ -2.5165 -1.1128 TD [(31.)-1266.5(Barnes)-224.7(PJ,)-229.3(Belvisi)-224.2(MG,)-227.2(Mak)-226.6(JCW)84.9(,)-224.2(Hadda)-227.9(E,)-220.9(O)]TJ /F17 1 Tf 21.049 0 TD 0 Tw (')Tj /F5 1 Tf 0.2213 0 TD [(Conner)-223.7(B.)]TJ -18.7537 -1.1128 TD [(T)28.6(iotropium)-182.5(bromide)-178.5(\(Ba679BR\),)-184.9(a)-176.3(novel)-183(long-acting)-179.1(mus-)]TJ T* [(carinic)-248.1(antagonist)-249.4(for)-240.7(the)-247.2(treatment)-251.3(of)-240.2(obstructive)-249.8(airways)]TJ 0 -1.1065 TD (disease.)Tj /F6 1 Tf 3.4333 0 TD [(Life)-336.2(Sci)]TJ /F5 1 Tf 3.408 0 TD [(1995;)-334.9(56:)-329.7(853\261859.)]TJ -9.3579 -1.1128 TD [(32.)-1266.5(Maesen)-573.5(FPV)121.2(,)-572(Smeets)-575.9(JJ,)-573.3(Sledsens)-574.2(TJH,)-572.1(W)70.8(ald)-576(FDM,)]TJ 2.5165 -1.1128 TD [(Cornelissen)-272.3(PJG.)-270(T)34.9(iotropium)-271(bromide,)-269.9(a)-271.2(new)-267.1(long-acting)]TJ T* [(antimuscarinic)-252.1(bronchodilator:)-256.3(a)-245.9(pharmacodynamic)-251.2(study)]TJ 0 -1.1065 TD [(in)-450.3(patients)-452.7(with)-448.6(chronic)-454.6(obstructive)-452.2(pulmonary)-455.7(disease)]TJ 0 -1.1128 TD (\(COPD\).)Tj /F6 1 Tf 3.8823 0 TD [(Eur)-332(Respir)-340.1(J)]TJ /F5 1 Tf 5.5073 0 TD [(1995;)-334.9(8:)-336.5(1506\2611513.)]TJ -39.9039 19.4935 TD (634)Tj 7.472 0 0 7.472 263.792 797.499 Tm 0.0001 Tc [(C.P)102.4(.)-334.1(V)126.3(A)0(N)-331.7(S)0.1(CHA)74.5(YCK)]TJ ET endstream endobj 28 0 obj << /ProcSet [/PDF /Text ] /Font << /F5 8 0 R /F6 9 0 R /F17 25 0 R >> /ExtGState << /GS2 15 0 R >> >> endobj 29 0 obj << /Type /Halftone /HalftoneType 1 /HalftoneName (Default) /Frequency 75 /Angle 45 /SpotFunction /Round >> endobj 30 0 obj << /Type /Halftone /HalftoneType 1 /HalftoneName (Default) /Frequency 75 /Angle 45 /SpotFunction /Round >> endobj 15 0 obj << /Type /ExtGState /SA false /OP false /BG /Identity /UCR /Identity /HT 29 0 R >> endobj 16 0 obj << /Type /ExtGState /SA true /OP true /BG /Identity /UCR /Identity /HT 30 0 R >> endobj 17 0 obj << /Type /ExtGState /SA true /OP false /BG /Identity /UCR /Identity /HT 30 0 R >> endobj 31 0 obj << /Type /FontDescriptor /Ascent 0 /CapHeight 0 /Descent 0 /Flags 4 /FontBBox [-170 -215 1009 704] /FontName /OFKEDA+AdvTT212dd343.BI /ItalicAngle 0 /StemV 0 /CharSet (/C82/C73/C83/C84/C86/C67/C69/C80) /FontFile3 32 0 R >> endobj 32 0 obj << /Filter /FlateDecode /Length 1256 /Subtype /Type1C >> stream Hdoe{swD%띹3d Q `Xf J5sle~ߵ^}kڮ֭2& TF%Fߌy5 HbLޟ|8>?p_^\]` * $T1I(CFiJE^C4iQ93$g鰄X/1A֑drVXYvAg2>b.3؊ZPcxԊ˄er0 oPlM@;#q2@<"#S,|i.y*H\Oc9}S|*dzݲ@G4 >ƐDt[?::.,rv.A)0Y~"p>X#Ο> endobj 34 0 obj << /Filter /FlateDecode /Length 1535 /Subtype /Type1C >> stream HdT{PTUg= 7L.6{ .. (j`YRA񅙮, B!"T(S3*3|6:g:|}|=S8BwB8X"kbV)}q<[[iP>؏x> (d)"*&6n܄S6h3 &4,,uJRjjD H5Ū([i`#G8.g# $K)"$I9NJIA6'qml$H!)&[Wd+cpjn 7~#$Uvw aIe/#=\StۮC=/vx E:\!J?phiڥ$LL@= [;z٣K>s,GLXX%Gx `m"t`acP/c0 ϝ)$>m5dD/dp vRƋ[嘎2 S߇==X74 #A/z L͂ΌFzfKȆ2b)L"k72v=C0U! ^#Q-z OA8&IY㱍S>_to.ӘV}QU7^eWTy,OI,? ͯ8ֲHVZSZ'3>m[{͝;ҹtO V2bQ}C!f@2c4QD#c`;`j;]u`< }^P!ܪ71&cփ3΃A&5!f]Ϟ B>+bD\8t/$!UX.?Q" wv}VgPe.*y+}qUbڦmD:Q8jڽF.pj&j-iikjkKJQS ɠb ݕOx>ryl{C#^`nQxE x717WrB ꡍv6.!aGRj&/)[/t1e1%3W:h11-=Wv^E{ Bvh?G_X}I{6e;?f ˤW# ;HD1A0C 6$J8w\Nr診2*lCl~k|0$hPy6U[@T6x d s|);)gPOOTuZ,_s剖?P. %_AD8hy.gy-|$E"dM2b~|KWU]ggYڧŒ7Yn]N~/m.WDiMyMe 24~hf4cc 'ifm!MVE)O.k8( {c8)? (|W +|z@ endstream endobj 35 0 obj << /Type /FontDescriptor /Ascent 0 /CapHeight 0 /Descent 0 /Flags 4 /FontBBox [-179 -292 1090 1010] /FontName /OFKEDE+AdvP697C /ItalicAngle 0 /StemV 0 /CharSet (/C62/C98/C109) /FontFile3 36 0 R >> endobj 36 0 obj << /Length 422 /Subtype /Type1C >> stream OFKEDE+AdvP697C G8 C62C98C109AdvP697C>bm"<zME[E[Mz2n}Ϭ𗻇ÀsdLҕavD&GdkxPk9"XYX|oTzrky{wbx{wszzK|Cl|gcugw]_l|xQ{ySIk̀zfkrr{wzmp{wz{|5}kgrtprmc endstream endobj 37 0 obj << /Type /FontDescriptor /Ascent 0 /CapHeight 0 /Descent 0 /Flags 4 /FontBBox [-165 -224 1000 775] /FontName /OFKEDG+AdvP6EC0 /ItalicAngle 0 /StemV 0 /CharSet (/C101/C111/C121/C52/C82/C112/C53/C73/C83/C103/C54/C74/C104/C114/C45/C75/C85/C105/C115/C46/C76/C116/C57/C67/C177/C97/C107/C117/C48/C58/C78/C108/C118/C49/C59/C69/C99/C50/C80/C100/C110/C51) /FontFile3 38 0 R >> endobj 38 0 obj << /Filter /FlateDecode /Length 2369 /Subtype /Type1C >> stream HtUkPW;Lw# 30 U ʈ`BhQ y*`}DWͺ ltML Qr=6nVjW}}swν(TJ!dXȌ܄` M)نh1piQ2O#4tQ:w>Mkf_xUyk֮QL4 # EK< MA9HA(H(M$ZLA$Es< Mf1,f1De̢","d,1D4!b<Ћ"àM$ C¦sHP$It%d2K8) !rԓͤ 9L#l'H%!ud )&d/9J ed%'&$夊' RW"Y\qhI(t( JQƾFO_j;`eFS iv 2W'1rdCz ,΂FKŢcND'NJZ6y01)`V\x>zr:v]ypzW@Qﵣ:٘'gC|kw:t 6ˀV&AO }dw&b[@ ˔ Bdiӹot?>±#]?kVoݺFPKF1IFtCcc. жܱgwfy͌҇M?z9 4Tۇ/8XqisnHe,xG!Es0 'N*5/=n~8[s^дP/w sxG!rVCx<cx8VYJXAorfqbzý|!meXpWZM0W׽glVsS_Tz%L{N]7'OeTދy >/O.f| s5+ǁVBL$Kq3}hFM.9X 6J]NwX!~kjߵlB}kE=`5LGe^_g-cJ2L/1 X@@C i249 u4b/rj-g#]uЈC BZ"·~{-OW K&ҠTZpm,4&aEy VWl>9hGw۫\kOΠOSA>}c=xN΋0G@z%mc 9B%pD_u|D&ƣ[mIzzJ錛eG2 vu>S_̯S͎e?D,3A=4׹A]'$BfE^=]R~[۹Oft_%GЊSYeun);W)߷|CZ ==ad8~P >p\;w uy o~5S], ڱ:?B#0b.ߨwR(;i dX #=Dgj),lƦ{@~)54GC~<:X hd ~k )̃`* (Me^ )ӗwXd㺏^I*;,rmVpE'ZϵwkBl+Q+_-+6>c;ۑL/Xov`_˖hgEn[}n8:e@7FK`1v}rk4H{&ew>X%oλӮT},bV6Q*0@-rfl>}nw'3\JqBV9SI1ew!Y=r2m0+Ռ8]g^)K{W]a";ߏZoax HqǪ=(zހ .vl߃g}=|Vm?OK%پY!.VrB5{̩3N=ǿ۟nϡϊ9GgQ endstream endobj 39 0 obj << /Type /FontDescriptor /Ascent 0 /CapHeight 0 /Descent 0 /Flags 4 /FontBBox [-76 -215 1008 717] /FontName /OFKEDI+AdvTT5843c571 /ItalicAngle 0 /StemV 0 /CharSet (/C101/C111/C121/C52/C38/C72/C82/C81/C102/C112/C122/C53/C73/C83/C93/C103/C113/C44/C34/C54/C74/C84/C63/C104/C114/C45/C55/C65/C75/C85/C105/C115/C46/C56/C66/C76/C86/C106/C116/C47/C57/C177/C77/C67/C97/C107/\ C117/C48/C58/C68/C78/C87/C98/C108/C118/C49/C59/C69/C79/C37/C99/C109/C40/C50/C119/C70/C80/C89/C100/C110/C41/C120/C51/C71/C90/C91) /FontFile3 40 0 R >> endobj 40 0 obj << /Filter /FlateDecode /Length 9799 /Subtype /Type1C >> stream HTTip>51r`vCM-[2~ )w 8>!Ye!|Ƈ,uY-Ye;` HLI#G2N3ә&(tUy<|B @٧G\ryN\ Ů<7&FUQˆ[_? d $ tln!)8~)p|p PH@PFZA0`NA0$`̃`<K,??/WkO 7\80 ^&"A&2P 3 Pv3d!.eq\$"~\2 qyC| 8<#HGB>C3WxS|f2p+Dܟ?=2Dv%G:ѪIZR FTr\fx@c;X|݉ٮ w~o|o2M r\!nƒ-YI]f'8[eZ%RJFIU SW*2s 0ՠ#&ÎP3Yd_"X5l͠쥜bKI}RB*j;&JC.i?2OdA1ި,̖JLj@Dj\ ^br1ECb)814jCT[ZcZė?pxȾ^[`Zhŀh x~uΙ_?*xR040:<HXKR UT%/<2KF \jU/ŎfdZ@LuFs'B~7*lB4JIFHf;s76zt|fd.8i=`v`X! l6hrc&wˉnmĀJK%\R)+X-+DbE3DIϼ̧ ᡞOw)r fr_JYyvGɇ>_Ўf0ƥ%#7 b;'ŏXCsoTLUߪ\x;,KܵZ*zK-0:|~xRCjr/K%2L|[ _'Kxś!.w[}oQ|XOuPIįvi=iNnNhj7pN`6K*Zyٿz4;ҵjKJRm(Y.u6ER4m9pɦ%iڬo"7bZ9Ǝ_O1ٙ}O["Baw'("1y]J+JDEs4W{M}sg,:~ ӤS.%3̑g9qc8:KJJLY0^%ޫTPEWLHjlzJX,͍x; :C^+iURl/oKȣyKܤ0wZ͆90sc~HK%Y@\9'1Q*jq<4Azl:Q6@spv}eY?3-i"]6K뿇6\uXEU\q -R7 g!7lbG_:+oP\ny,$;2!>j?T-UW#hgjkh9uگ/77S UQJsJ ^gGЯF&jk&`Ety3st~U@ڑ DM~=[ ղ \9YND=inC㓳IxfQp|:TOaij6¸%&Qs^qg[AٕP ޛ0 dӻOe"g]mkw$A nRqdd|Jz6jٍP^눵^9ټUo,e԰/+HE?{Α:T;N*!cؘƐVRJ|Kf3i_& bey"i;e!&#cRaﻊG=W a [̐х[1XcHf\r/AKJ$\\ Zqv޿tsq4? z?4G{c^=CNDa_>{ NNcVQvi>-6bS-a~݌D(Hb CsD׀hH;a~-D򧭡0ZK4ڔd:U.奩cq9OZJ;ۥ.^L=oD=M~;zgG"z1"^bڵj=W@*-@ug\Aއ{F=7:thrΚ*x8 F"h8&7d&K%TOH2] /µ2K u'8hLjĚ8 .<}IQ7o[YHam><|Vn#iؚmum]֦v/V=86'K&Ơ\.! dTC&d\̋w[J+z 'īuhcU  u[IVg$uaojqI%I@٧!^rRWA|\Ws^:v)+İ<,T5x eNAcZ0YJb#q0;[f(9CGĒ<2gW=TOm<x,<7CxwDGlcͨ:[ >_Pò {ksN:h@ae#ф6kDe >H?.譻?Do!SEP?.x&#.U3@oM=݇>cZ.Ehړ`"-ϻvö 4aJh\?=ca/`)ͶVXv[|*RAv4d6z&ȡwn:*$ăr(E!g=gӃHdjDRIOz"/- >.9ޕ⎘9:22xk%M|,Ƹ'Ȃ+0Фa!icY\F::cw+|bGW䅴Kq.ʄ@Be&iܓB n"&e􉤧vMs0 Ѥ1JApnq֞D!0R= 8_*5yq.*mKt59B8'۱^mmWx)&oRIDӾMWi]qZ7i9ز[dYe(/")He]l&RH,&ˆ ʠ$as9ØO+IzaYm?d#l>g Z1 DDֲ`]ĕߔ+7gB].q=؀ںxeha%IYE+%4_г?UOL~xS$Е xJ!#0G/: 'Ip!v~@JBŌ~צ )86-_@'ja76\v|,̉G)픡D,HE7p` U{D^-#|8 X2NhNUd_ ZӨ95} >hyϺ}pf?|KGȿ3w\VJ2WO77L@N %O/$fKܬr Y$fNvEX44i=S(u'5tDjpO# ?V'!.?NcD!Zat#st^bxԃGG]Qi2ve5̵?E+/^ص߽SHC@9R˽rok kOHYp^EET$1L<BT -893=̳5(Q|1h хy:fp>.NíS&R3p`&T#246%`RYEr1ӂh1h?֍G+l+zk5[)i"5"uS{Kj(eJ a| ;؊iU^)g"2(E#iv+,ҡ-R"%x:R]UWj|Z)zQHYVZe:E<,30؀.6W6i2ęc iG;1TEVڢwj^ZlR|miU-ki::/Ʃ:3=_ 9Ep =z6MbK#;l֮CaȆ!fA,sib˶,˔DRDQtEEQ(Q"vvҤWb[ ذ`0`׻A+G }ssH55 ׬۷@eVzIqUc^ c~.HN gyS&$Rmh[9$M3gW~'_m²\hH,A0`CDt.pt(0n+^jd)YG&obt [r$WI[f*Q+c^+![@<(4i 5'gy\3[$\n/=oÅ?<7޻;SΣ.r9]ר%vM^,GggDh1g´ɔYx=%(Bp9g:\YiYr$Z% FqM FB!rq{1UD,(IYU")0T WZ}t}@R8CR3S@y@e߆|@~Y?chiP೘L'!08:xNt "*dOV%4E`~c\>k=5s~Ϻ2;IO''%-<^y~s遝fr\y, WE paxTH 3B;RSUDj9:D9F,΢:>7D A )#jdR Ȯ5{֍4ŕ-PLیU2^,7 'Αh^,)b, =\fԥeL.;۽ieV"4>ݯW!]X$m(rK 7p;G ?E[2ʘ<"#<{Tu _MGw{[SFD7A:FDzlv ϧ =1-dQQ=y=usw_ 3[ endstream endobj 41 0 obj << /Type /FontDescriptor /Ascent 0 /CapHeight 0 /Descent 0 /Flags 4 /FontBBox [-172 -215 986 700] /FontName /OFKEDK+AdvTTf90d833a.I /ItalicAngle 0 /StemV 0 /CharSet (/C101/C111/C121/C82/C102/C112/C73/C83/C103/C74/C84/C104/C114/C65/C105/C115/C46/C66/C76/C116/C67/C77/C97/C117/C68/C78/C98/C108/C118/C69/C99/C109/C80/C90/C100/C110/C120/C71) /FontFile3 42 0 R >> endobj 42 0 obj << /Filter /FlateDecode /Length 6253 /Subtype /Type1C >> stream H\U[l<X[3bW!uK.B$!7 q_x/cx8N8!UՔ}}AݭPU}PSU*K9wuk4N=ч߫n={jSeyyþc|; ?*XqsVڪ~%i{Լ v8﾿t~|.\rz[ay)k67FXe<`6+aWn64W'XƃCx|\Qa6ULf\e\Qi6U*Oa+U*U+,#& ;5`>M1pb)͙54 hۺuv @(w@D@ 10 A6H 9 Q q0f@ !0`i@545\XkXj]N[9Y)KGvCk7~)[vo߶goެ;S_ VWXټ?(0$^Fi%XY'D<"ɤ,E$Yo6yJ8rmp;z9+whZDLkmT8ƑlTX4 KDXRc^=p&9` <ڏ 3`K7ȋ8Eދ*ST&;Cs,L'{hcj98>=Ns,ueW;ݦJ۵h^`´k5 xqvur&~"U3AYJ6,I5bv"n%+ՐwŲ|x_?st( [chi=\6d.uDeYx}Yrr\_ڍ7hfCm䥑-d}dzrbyrzGOSF>M$xZnrs4DJOBbdahVENc1Quu0|"\" ctvC4 "qkl:Z,n % vTf0yyX }ZKXk-ǎVWz.!0GP "{NKV݋>Eq):N1:va~OEAmt{ɮ5N]ePfOoԡ>a>OO!Mc?8M6ؚ:Z᧽zϝzbn- WxvH&Ļc^Y&E)$ET"`dD_Fx62~6I|7qA;],YH˒2}C 2N]Csڟu ڃl aAD/ȸ U+RJS1SP C1PA*I41FBG|Ǖt*BYqdЏ^UX(zzyo/s̕Dfn8R[+f<nˇr.W½lPI^ Q, #rS`JDa:)&ic]r﨓pfK=xn&3ZH;uI?49Tʸ`$/$zR@^kʲA8h?`/0K I];?DK儈J&Ð]0Pj~5B!`BЍL'Cn/l=p|^1Hd 2g nv14ꢺ9 AJov`o ( @1v@qQ2y0_?b3H=,$# RKFbYBݒJY)aYGXp. ʊ̧%YV7yGo\\ғ=}`LTA{ pUK)f uCިrm#-;Pd> !!!.EE,BTmɦiMıǎsx}[9yR5ؗzPI|Y4akc2[P/q5=s'/ ʟe] ʳY& c1y1"v_"I-\7Mܢ,"b>o>6T]{ i/΂Ic{ޯXMsڻZ;`.p#|0, ^S&1oocvjTXD6sDX]hia8?đcf<3X7^O4ّ f8j&Y g4 MՆgG}͒2TP5s_;s*~DBQ~Rh،ULI t6ΛmM@ñ;YaCW5D6!jxyZBHzdxJclCdJhΈ!tE ©0x%dGKYؕ[)y,fKy/loaEqS%iprlߌ3Tİ$|״,'ƖhXm+jA~l=!Ob>~rk]u@ >'W%`p9t&%HDgss~q ^WhtC,hvw^ta"I0H9r^Z5_1KVn;y")x~7,Q4Z5x;Mh^|o§Rh&X|ydѲp|~fnj߁RmeyxV9ʇR+>'+'}|uI}UlMe"%T>Brq]R>ύ`&)$&53|e,2r$MbeZ~ur^/7˪ h ID4< |v0yhuidEvD8C!ܘĈDKXh<' ק ?`Ah=9|<=<L$HW>=ʻھ4Z/MXe*(Of.+94§gyI7 6YG(ew$>JZ htc ֕tu**O7{]hgwG퀲gf͆WH ̅<3ZmTH.*d")8"{3d;; lF}uxpxS#ghܬ$=6~?}ոC8I3:yJQ04AdĄWɋȀ@{$ԟ@$!wWE ~ ]pe+ EqHlGw:L'7cJ'CD(905>Az(ա[ۍ\P`ٔ ;33th%JESKI2OP$@ ;[~h>zvP*hI~O4ܗ Y<`n7+bYdSlVM6'"hzք4i8&azowiK|{c}$d5iEO EDrt&癥 ą%&2jL&YlLoLV %( R@dl6b5 .!B,O*%Y@B cm:[h=Ӥ[8 oLVh! ^zk5Xs[Hm`w 渣 ΟD5 ࣁ;fR'4ۂUkzJv$`h: $> o򪦣ֻh^ ,fbP|&:\M0CReY-dsѭL* Lp[]jhfὫ*ɒ$>V F|Mj+|lnU.[7{矋O QD$)Wm,o5^ T"NHO'{|:eǖMZy5\"Ձ߿kSQ GK+V"B 0&A2O,.p)6aF~1[_Y?\.gZ:}&Y&XZUHâ!yrBaq2Mr8E#^59(dbiNpD&#YNBA( LNt֯?K?7h$f9lFJtƕD>M±x(&yww2>hm֫iY$ 4V ̶T"TUQKX.OI*IQ)&5 u6W+ɊW{6*Wm g,"s`2v!27HA$Af1)˭ӳdfMIdDѴ2NxNV|7E V>>tz ^w\g6DxWdVPFau9$K%9y$WlLF#Kdtb8}ohݾ}v =?E endstream endobj 43 0 obj << /Type /FontDescriptor /Ascent 0 /CapHeight 0 /Descent 0 /Flags 4 /FontBBox [-27 -215 1009 696] /FontName /OFKEDM+AdvTT2cba4af3.B /ItalicAngle 0 /StemV 0 /CharSet (/C101/C111/C121/C82/C102/C112/C103/C84/C104/C114/C45/C105/C115/C116/C97/C117/C98/C108/C118/C99/C109/C50/C100/C110) /FontFile3 44 0 R >> endobj 44 0 obj << /Filter /FlateDecode /Length 3371 /Subtype /Type1C >> stream H\U[lS[8dje g?}DGw\z{O]{r9o/ ̽jB }W5o8u;qs_z{;uvv=elýǺ`]ch#=Gp1kXoO1} t:/e MSi\oj#)*Aq( I  ( @EHxS( PAy(fo0cj3j@s/teW{|-oxszO}3GvwJii͘;>?f Da!g܊6nwmH#1r]An1|̾ѥ:gnҊ 0Dž޷/5 ܡ5xdѭGj&#Ylv}Jq +&N5K|Ugo'y̳2cE&p5x'̈́X1JWa;!p*Mg8 p*3-5]kOqtaAwрvY]gnU^}v<™MumSh<~kINe|UMT$R/"F9sX*&0T$[]TNYcln$+FH`VPe\ "y*%N bJ UT9V%&C$\Vd~kWmv`'Ct$+U: |^mTCRDTV_[w ;\|DL &A:?/6UB j~FruZ|Y_.uCdM60ۍ?OJѡa\OٛږR  ^rdN"ǹOh;F^*T#Q)Nt@L"Vu}&C ?Gܙz~uZt=AWhKu[7r<ωZ7r#ao(@y.:L6Qҧ/ cSj%UqUh ^`R`p:c9CQ*=-Mrp`8apLi,p#[5s* JIm,9js鼅KXhC΋!ϙ"}5;Or%|<:sg<+rX  x-yC_ۋIE1QȦ$4#𜀧DAqb8CB"©h=%ᒷ<ANF'loOiGa\${P^-Gˀ2?7-DƆMzgmeVv,7+ jYB*u@E~ , 5 i6nqwGb.JUP#2Vp GnR $QR9I$INحr<2PkمD4F9T5ΘR@sx%E A?||&V4LSR'w/~ q +AM24F9Ƙc#(&aTM4&QVI3bx;bP%b%ؓ2 o":JQ΂( aL2 Ҽ[yKc4dV+I f+UxnU4qv2rz@W[G<&@U65Ao'! A&1ئ mce]'dMűq6ڮ:mBȝlji<{(#hZ%a(z먶Mؖx:E(R#qrWC< Ň:EKTKug|x|zZuTwa?*e ɃWPZY&+CVY48,VUf8!ʙjo#O|"V(J} \n\C,}/obiZj'?s#dTVͫe{X; kv3=[f8K|/=(v`HT&3L$Ee`e^ 'Hʭ 60ڄ3o|v=R9_IXcs݅Qlz۩$ETDyl\M䜘*8W) ٰG$RYYP$H͚!";McW]c@4\D2M[p0x7L w&*KBHiG/;9 $QՕ aJ;;OýEn,~720&EfWITDˮ@~R ޜLvT]kaR ޺ypE5Dt`ԕUtȮP}XBjڒ CufWm>FӠ;oLbu ą ѳ /L-2̶I ݻA&.沅 &O$]Cks )!dY1eU )Rar?8VYOT}h̨\I[KtuEiy-{k4f)&7棱R??rګ]N8@eAJ,?zg&jȚMhؘ$bI_:8]I*yD=hf/44'-rhZ#{9Dxлco(C!5[8H ~"ߟ(l+mTm(+JYcBmݍzCߋ;TCY endstream endobj 45 0 obj << /Type /FontDescriptor /Ascent 0 /CapHeight 0 /Descent 0 /Flags 4 /FontBBox [-11 -345 1373 718] /FontName /OFKICH+AdvPi3 /ItalicAngle 0 /StemV 0 /CharSet (/C35) /FontFile3 46 0 R >> endobj 46 0 obj << /Filter /FlateDecode /Length 831 /Subtype /Type1C >> stream H,RˎDw%4l2;,"! )b 3vo;w"7HH| aEUT9_w_}ͳ?GOO"O/k/|||8WOp:&c6C>VS;y^U]e[e_ r",.uٞ=0#b dJ8)N*®'EЇij3dz'7ӻUҤC:eWuyVM^guriȆ $ T}4^` S5zaA'o?'(3(087&8f ~x+]s~.}|HG6[k8'\-JհB -H efOөCf+Uߢƺun=5j#C $+M K5`ЌVgDmL@B^dItIl+j-jvnǼ0<:ڬ ^_)έЂB`H 語!ƄYP< Pe9L JiiN5F4Qw5lO.;Mp)lYK;ֲqmǚWޚUe(s}ZhffPy[LŒIנ,d- O;,HFsB>E6A6Z K6K #LJW endstream endobj 47 0 obj << /Type /FontDescriptor /Ascent 0 /CapHeight 0 /Descent 0 /Flags 4 /FontBBox [13 -323 958 824] /FontName /OFKMBB+AdvPi1 /ItalicAngle 0 /StemV 0 /CharSet (/C39) /FontFile3 48 0 R >> endobj 48 0 obj << /Length 156 /Subtype /Type1C >> stream OFKMBB+AdvPi1 R. C39AdvPi1'Jn0T] endstream endobj 49 0 obj << /Type /FontDescriptor /Ascent 718 /CapHeight 718 /Descent -207 /Flags 32 /FontBBox [-136 -225 820 931] /FontName /Helvetica-Narrow /ItalicAngle 0 /StemV 88 /XHeight 523 >> endobj 50 0 obj << /Type /FontDescriptor /Ascent 718 /CapHeight 718 /Descent -207 /Flags 96 /FontBBox [-139 -225 915 931] /FontName /Helvetica-Narrow-Oblique /ItalicAngle -12 /StemV 88 /XHeight 523 >> endobj 4 0 obj << /Type /Font /Subtype /Type1 /Name /F1 /FirstChar 32 /LastChar 251 /Widths [250 385 552 500 500 822 770 322 322 322 500 562 250 322 250 270 500 500 500 500 500 500 500 500 500 500 322 322 562 562 562 500 822 666 666 666 718 666 666 718 770 385 500 666 604 885 718 718 604 718 666 552 604 718 666 885 666 604 604 322 270 322 562 500 322 500 500 437 500 437 322 500 552 270 270 500 270 770 552 500 500 500 385 385 270 552 437 666 500 437 385 343 218 343 562 0 0 0 0 0 718 500 604 500 750 750 0 541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 385 500 500 0 500 500 500 500 270 500 500 322 322 0 0 0 500 500 500 250 0 500 343 322 500 500 500 1000 1000 0 500 0 322 322 322 322 0 0 0 322 0 0 322 0 0 0 0 1000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 937 0 260 0 0 0 0 0 718 937 291 0 0 0 0 0 718 0 0 0 0 0 0 0 500 718 500 ] /Encoding 51 0 R /BaseFont /OFKEDA+AdvTT212dd343.BI /FontDescriptor 31 0 R >> endobj 5 0 obj << /Type /Font /Subtype /Type1 /Name /F2 /FirstChar 32 /LastChar 251 /Widths [281 333 479 552 552 885 718 281 333 333 385 583 281 333 281 281 552 552 552 552 552 552 552 552 552 552 333 333 583 583 583 614 979 718 718 718 718 666 614 781 718 281 552 718 614 833 718 781 666 781 718 666 614 718 666 947 666 666 614 333 281 333 583 552 281 552 614 552 614 552 333 614 614 281 281 552 281 885 614 614 614 614 385 552 333 614 552 781 552 552 500 385 281 385 583 0 0 0 0 0 718 614 666 614 833 833 0 583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 333 552 552 166 552 552 552 552 239 500 552 333 333 614 614 0 552 552 552 281 0 552 354 281 500 500 552 1000 1000 0 614 0 333 333 333 333 333 333 333 333 0 333 333 0 333 333 333 1000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1000 0 375 0 0 0 0 614 781 1000 364 0 0 0 0 0 885 0 0 0 281 0 0 281 614 947 614 ] /Encoding 52 0 R /BaseFont /OFKEDC+AdvP6EC5 /FontDescriptor 33 0 R >> endobj 6 0 obj << /Type /Font /Subtype /Type1 /Name /F3 /FirstChar 32 /LastChar 254 /Widths [250 333 708 500 552 833 781 437 333 333 500 552 250 552 250 281 500 500 500 500 500 500 500 500 500 500 281 281 552 552 552 447 552 718 666 718 614 614 760 604 718 333 635 718 687 885 718 718 770 739 552 593 614 687 437 770 645 791 614 333 864 333 656 500 500 635 552 552 489 437 520 406 604 333 604 552 552 572 520 552 552 520 552 604 437 572 708 687 489 687 489 479 197 479 552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 625 250 552 166 708 500 750 750 750 750 1041 989 604 989 604 395 552 406 552 552 708 489 458 552 552 552 552 1000 604 1000 656 822 687 791 989 770 770 822 770 770 708 708 708 708 708 708 708 770 708 791 791 885 822 552 250 708 604 604 1041 989 604 989 604 489 333 791 791 781 708 385 385 385 385 385 385 489 489 489 489 0 333 270 687 687 687 385 385 385 385 385 385 489 489 489 ] /Encoding 53 0 R /BaseFont /OFKEDE+AdvP697C /FontDescriptor 35 0 R >> endobj 7 0 obj << /Type /Font /Subtype /Type1 /Name /F4 /FirstChar 32 /LastChar 251 /Widths [281 281 354 552 552 885 666 218 333 333 385 583 281 333 281 281 552 552 552 552 552 552 552 552 552 552 281 281 583 583 583 552 1010 666 666 718 718 666 614 781 718 281 500 666 552 833 718 781 666 781 718 666 614 718 666 947 666 666 614 281 281 281 468 552 218 552 552 500 552 552 281 552 552 218 218 500 218 833 552 552 552 552 333 500 281 552 500 718 500 500 500 333 260 333 583 0 0 0 0 0 718 552 666 552 833 833 0 583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 333 552 552 166 552 552 552 552 187 333 552 333 333 500 500 0 552 552 552 281 0 541 354 218 333 333 552 1000 1000 0 614 0 333 333 333 333 333 333 333 333 0 333 333 0 333 333 333 1000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1000 0 375 0 0 0 0 552 781 1000 364 0 0 0 0 0 885 0 0 0 281 0 0 218 614 947 614 ] /Encoding 52 0 R /BaseFont /OFKEDG+AdvP6EC0 /FontDescriptor 37 0 R >> endobj 8 0 obj << /Type /Font /Subtype /Type1 /Name /F5 /FirstChar 32 /LastChar 251 /Widths [250 322 406 500 500 822 770 322 322 322 500 562 250 322 250 270 500 500 500 500 500 500 500 500 500 500 270 270 562 562 562 437 916 718 666 666 718 604 552 718 718 322 385 718 604 885 718 718 552 718 666 552 604 718 718 937 718 718 604 322 270 322 468 500 322 437 500 437 500 437 322 500 500 270 270 500 270 770 500 500 500 500 322 385 270 500 500 718 500 500 437 479 197 479 531 0 0 0 0 0 718 500 552 500 750 750 0 541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 322 500 500 0 500 500 500 500 177 437 500 322 322 0 0 0 500 500 500 250 0 447 343 0 437 0 500 1000 1000 0 437 0 322 322 322 322 0 0 0 322 0 0 322 0 0 0 0 1000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 885 0 270 0 0 0 0 0 718 885 302 0 0 0 0 0 666 0 0 0 0 0 0 0 500 718 500 ] /Encoding 54 0 R /BaseFont /OFKEDI+AdvTT5843c571 /FontDescriptor 39 0 R >> endobj 9 0 obj << /Type /Font /Subtype /Type1 /Name /F6 /FirstChar 32 /LastChar 251 /Widths [250 322 416 500 500 822 770 322 322 322 500 666 250 322 250 270 500 500 500 500 500 500 500 500 500 500 322 322 666 666 666 500 916 604 604 666 718 604 604 718 718 322 437 666 552 822 666 718 604 718 604 500 552 718 604 822 604 552 552 385 270 385 416 500 322 500 500 437 500 437 270 500 500 270 270 437 270 718 500 500 500 500 385 385 270 500 437 666 437 437 385 395 270 395 531 0 0 0 0 0 718 500 604 500 750 750 0 541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 385 500 500 0 500 500 500 500 208 552 500 322 322 0 0 0 500 500 500 250 0 520 343 322 552 552 500 885 1000 0 500 0 322 322 322 322 0 0 0 322 0 0 322 0 0 0 0 885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 885 0 270 0 0 0 0 0 718 937 302 0 0 0 0 0 666 0 0 0 0 0 0 0 500 666 500 ] /Encoding 51 0 R /BaseFont /OFKEDK+AdvTTf90d833a.I /FontDescriptor 41 0 R >> endobj 10 0 obj << /Type /Font /Subtype /Type1 /Name /F7 /FirstChar 32 /LastChar 251 /Widths [250 322 552 500 500 1000 822 322 322 322 500 562 250 322 250 270 500 500 500 500 500 500 500 500 500 500 322 322 562 562 562 500 927 718 666 718 718 666 604 770 770 385 500 770 666 937 718 770 604 770 718 552 666 718 718 1000 718 718 666 322 270 322 572 500 322 500 552 437 552 437 322 500 552 270 322 552 270 822 552 500 552 552 437 385 322 552 500 718 500 500 437 385 218 385 510 0 0 0 0 0 718 500 604 552 750 750 0 541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 322 500 500 0 500 500 500 500 270 500 500 322 322 0 0 0 500 500 500 250 0 531 343 322 500 500 500 1000 1000 0 500 0 322 322 322 322 0 0 0 322 0 0 322 0 0 0 0 1000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1000 0 291 0 0 0 0 0 770 1000 322 0 0 0 0 0 718 0 0 0 0 0 0 0 500 718 552 ] /Encoding 51 0 R /BaseFont /OFKEDM+AdvTT2cba4af3.B /FontDescriptor 43 0 R >> endobj 11 0 obj << /Type /Font /Subtype /Type1 /Name /F8 /FirstChar 33 /LastChar 126 /Widths [1000 1000 1000 1000 1104 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 0 1000 1000 1000 1000 1000 1000 1000 1000 0 1218 0 770 1000 1000 1000 1000 822 822 666 822 666 718 822 718 666 666 718 666 1000 822 822 822 822 822 822 718 718 822 1000 666 822 718 1000 333 1000 1000 0 0 1000 822 718 822 666 1000 718 1104 822 885 1104 1000 1104 1156 666 822 666 822 937 1000 822 1000 1156 822 822 937 1000 1000 1156 1000 ] /Encoding 55 0 R /BaseFont /OFKICH+AdvPi3 /FontDescriptor 45 0 R >> endobj 12 0 obj << /Type /Font /Subtype /Type1 /Name /F10 /Encoding 56 0 R /BaseFont /Symbol >> endobj 25 0 obj << /Type /Font /Subtype /Type1 /Name /F17 /FirstChar 33 /LastChar 126 /Widths [1000 437 1000 385 1000 1000 218 1000 1000 1000 1000 1000 0 500 1000 1000 1000 0 0 1000 1000 1000 1000 385 1000 1000 1000 666 1000 666 1000 385 0 437 822 666 437 718 666 666 0 0 552 718 0 0 718 822 0 552 666 0 718 1000 552 666 822 666 437 822 437 1000 1000 0 552 552 666 500 437 666 500 885 333 666 552 552 552 500 666 552 500 552 666 437 500 0 552 500 500 437 500 0 385 822 ] /Encoding 57 0 R /BaseFont /OFKMBB+AdvPi1 /FontDescriptor 47 0 R >> endobj 13 0 obj << /Type /Font /Subtype /Type1 /Name /F13 /FirstChar 32 /LastChar 255 /Widths [228 228 291 456 456 729 547 157 273 273 319 479 228 273 228 228 456 456 456 456 456 456 456 456 456 456 228 228 479 479 479 456 832 547 547 592 592 547 501 638 592 228 410 547 456 683 592 638 547 638 592 547 501 592 547 774 547 547 501 228 228 228 385 456 273 456 456 410 456 456 228 456 456 182 182 410 182 683 456 456 456 456 273 410 228 456 410 592 410 410 410 274 213 274 479 0 547 547 592 547 592 638 592 456 456 456 456 456 456 410 456 456 456 456 228 228 228 228 456 456 456 456 456 456 456 456 456 456 456 328 456 456 456 287 440 501 604 604 820 273 273 0 820 638 0 479 0 0 456 456 0 0 0 0 0 303 299 0 729 501 501 273 479 0 456 0 0 456 456 820 0 547 547 638 820 774 456 820 273 273 182 182 479 0 410 547 137 456 273 273 410 410 456 228 182 273 820 547 547 547 547 547 228 228 228 228 638 638 0 638 592 592 592 228 273 273 273 273 273 273 273 273 273 273 ] /Encoding 58 0 R /BaseFont /Helvetica-Narrow /FontDescriptor 49 0 R >> endobj 14 0 obj << /Type /Font /Subtype /Type1 /Name /F15 /FirstChar 32 /LastChar 255 /Widths [228 228 291 456 456 729 547 157 273 273 319 479 228 273 228 228 456 456 456 456 456 456 456 456 456 456 228 228 479 479 479 456 832 547 547 592 592 547 501 638 592 228 410 547 456 683 592 638 547 638 592 547 501 592 547 774 547 547 501 228 228 228 385 456 273 456 456 410 456 456 228 456 456 182 182 410 182 683 456 456 456 456 273 410 228 456 410 592 410 410 410 274 213 274 479 0 547 547 592 547 592 638 592 456 456 456 456 456 456 410 456 456 456 456 228 228 228 228 456 456 456 456 456 456 456 456 456 456 456 328 456 456 456 287 440 501 604 604 820 273 273 0 820 638 0 479 0 0 456 456 0 0 0 0 0 303 299 0 729 501 501 273 479 0 456 0 0 456 456 820 0 547 547 638 820 774 456 820 273 273 182 182 479 0 410 547 137 456 273 273 410 410 456 228 182 273 820 547 547 547 547 547 228 228 228 228 638 638 0 638 592 592 592 228 273 273 273 273 273 273 273 273 273 273 ] /Encoding 58 0 R /BaseFont /Helvetica-Narrow-Oblique /FontDescriptor 50 0 R >> endobj 51 0 obj << /Type /Encoding /Differences [] >> endobj 52 0 obj << /Type /Encoding /Differences [] >> endobj 53 0 obj << /Type /Encoding /Differences [] >> endobj 54 0 obj << /Type /Encoding /Differences [] >> endobj 55 0 obj << /Type /Encoding /Differences [] >> endobj 56 0 obj << /Type /Encoding /Differences [] >> endobj 58 0 obj << /Type /Encoding /Differences [ 0/NUL/SOH/STX/ETX/EOT/ENQ/ACK/BEL /BS/HT/LF/VT/FF/CR/SO/SI /DLE/DC1/DC2/DC3/DC4/NAK/SYN/ETB /CAN/EM/SUB/ESC/FS/GS/RS/US 39/quotesingle 96/grave 127/DEL/Adieresis/Aring/Ccedilla/Eacute/Ntilde /Odieresis/Udieresis/aacute/agrave/acircumflex/adieresis/atilde/aring /ccedilla/eacute/egrave/ecircumflex/edieresis/iacute/igrave/icircumflex /idieresis/ntilde/oacute/ograve/ocircumflex/odieresis/otilde/uacute /ugrave/ucircumflex/udieresis/dagger/degree 164/section/bullet/paragraph /germandbls/registered/copyright/trademark/acute/dieresis/notequal/AE /Oslash/infinity/plusminus/lessequal/greaterequal/yen/mu/partialdiff /summation/product/pi/integral/ordfeminine/ordmasculine/Omega/ae /oslash/questiondown/exclamdown/logicalnot/radical/florin/approxequal/Delta /guillemotleft/guillemotright/ellipsis/nbspace/Agrave/Atilde/Otilde/OE /oe/endash/emdash/quotedblleft/quotedblright/quoteleft/quoteright/divide /lozenge/ydieresis/Ydieresis/fraction/currency/guilsinglleft/guilsinglright/fi /fl/daggerdbl/periodcentered/quotesinglbase/quotedblbase/perthousand/Acircumflex/Ecircumflex /Aacute/Edieresis/Egrave/Iacute/Icircumflex/Idieresis/Igrave/Oacute /Ocircumflex/apple/Ograve/Uacute/Ucircumflex/Ugrave 246/circumflex/tilde /macron/breve/dotaccent/ring/cedilla/hungarumlaut/ogonek/caron ] >> endobj 57 0 obj << /Type /Encoding /Differences [] >> endobj 1 0 obj << /Type /Page /Parent 18 0 R /Resources 3 0 R /Contents 2 0 R >> endobj 19 0 obj << /Type /Page /Parent 18 0 R /Resources 21 0 R /Contents 20 0 R >> endobj 22 0 obj << /Type /Page /Parent 18 0 R /Resources 24 0 R /Contents 23 0 R >> endobj 26 0 obj << /Type /Page /Parent 18 0 R /Resources 28 0 R /Contents 27 0 R >> endobj 18 0 obj << /Type /Pages /Kids [1 0 R 19 0 R 22 0 R 26 0 R] /Count 4 /MediaBox [0 0 595 842] >> endobj 59 0 obj << /Type /Catalog /Pages 18 0 R >> endobj 60 0 obj << /CreationDate (D:191000316095556) /Producer (\376\377\000A\000c\000r\000o\000b\000a\000t\000 \000D\000i\000s\000t\000i\000l\000l\000e\000r\000 \0003\000.\0000\0002) /Creator (3B2 Total Publishing 6.03d/W) /Title (99-1086 631..634) >> endobj xref 0 61 0000000000 65535 f 0000111628 00000 n 0000000017 00000 n 0000018173 00000 n 0000099724 00000 n 0000100665 00000 n 0000101626 00000 n 0000102656 00000 n 0000103618 00000 n 0000104552 00000 n 0000105490 00000 n 0000106435 00000 n 0000107035 00000 n 0000107702 00000 n 0000108773 00000 n 0000069233 00000 n 0000069342 00000 n 0000069449 00000 n 0000111993 00000 n 0000111717 00000 n 0000018423 00000 n 0000043654 00000 n 0000111809 00000 n 0000043847 00000 n 0000064057 00000 n 0000107140 00000 n 0000111901 00000 n 0000064211 00000 n 0000068836 00000 n 0000068967 00000 n 0000069100 00000 n 0000069557 00000 n 0000069811 00000 n 0000071166 00000 n 0000071496 00000 n 0000073130 00000 n 0000073358 00000 n 0000073856 00000 n 0000074255 00000 n 0000076723 00000 n 0000077272 00000 n 0000087170 00000 n 0000087560 00000 n 0000093912 00000 n 0000094245 00000 n 0000097715 00000 n 0000097930 00000 n 0000098859 00000 n 0000099072 00000 n 0000099304 00000 n 0000099509 00000 n 0000109852 00000 n 0000109912 00000 n 0000109972 00000 n 0000110032 00000 n 0000110092 00000 n 0000110152 00000 n 0000111568 00000 n 0000110212 00000 n 0000112104 00000 n 0000112161 00000 n trailer << /Size 61 /Root 59 0 R /Info 60 0 R /ID [<5cf32e45a1c844568ea61a5dea70ac1d><5cf32e45a1c844568ea61a5dea70ac1d>] >> startxref 112422 %%EOF 1 0 obj << /Type /Page /Parent 18 0 R /Resources 3 0 R /Contents 2 0 R /Thumb 64 0 R >> endobj 19 0 obj << /Type /Page /Parent 18 0 R /Resources 21 0 R /Contents 20 0 R /Thumb 66 0 R >> endobj 22 0 obj << /Type /Page /Parent 18 0 R /Resources 24 0 R /Contents 23 0 R /Thumb 68 0 R >> endobj 26 0 obj << /Type /Page /Parent 18 0 R /Resources 28 0 R /Contents 27 0 R /Thumb 70 0 R >> endobj 60 0 obj << /CreationDate (D:191000316095556) /Producer (\376\377\000A\000c\000r\000o\000b\000a\000t\000 \000D\000i\000s\000t\000\ i\000l\000l\000e\000r\000 \0003\000.\0000\0002) /Creator (3B2 Total Publishing 6.03d/W) /Title (99-1086 631..634) /ModDate (D:20000316100314) >> endobj 61 0 obj [ /Indexed /DeviceRGB 255 62 0 R ] endobj 62 0 obj << /Filter [ /ASCII85Decode /LZWDecode ] /Length 63 0 R >> stream J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T (7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4 PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD' dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\ 9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue> gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R endstream endobj 63 0 obj 488 endobj 64 0 obj << /Filter [ /ASCII85Decode /LZWDecode ] /Width 74 /Height 105 /ColorSpace 61 0 R /BitsPerComponent 8 /Length 65 0 R >> stream J2Q7]3$]7K#D>EP:q1$o*=mro@So+\<\5,=TOSSDU'ijO%=#fhZ.SsO7ji_kAb&siDK?=sW)rUG>h-;HVT@rhFN_r7#7],.[(:KgcVpdb lo('p[PK)@hoP0%-9Zir(;mM/qfcCaqBZ0.E[gTXXhR-bdB$tL^3~> endstream endobj 65 0 obj 524 endobj 66 0 obj << /Filter [ /ASCII85Decode /LZWDecode ] /Width 74 /Height 105 /ColorSpace 61 0 R /BitsPerComponent 8 /Length 67 0 R >> stream J2Q7]3$]7K#D>EP:q1$o*=mro@So+\<\5,H7Uo;k$3i4*O@UU:3@'nb-\f]R;Rp>< #;)<:A($d0em/?H:1eIeeE1+$R7\l)=p3E+7ZUAXPZ`\]>1]@`VD2gs2MY@jTW'=\6iXO]dBSo0ICbN/)89Fc7qA^F'An_IKJs-U(SFF!-URp1i^ ?#85#L%AlZgMg[#$uUOcWln/3q>M0gKtQ1'2n7-Y.qd.fF?81eX=(4!l!?GWMC4Dr ho/iIHd;)P\Sg2A]i&3-Rf2]tpqK#M-hlEoU#6%W!PjdJ%0AGFMS9'?844p_r$Co,S Lm35-`A.j'+N4pt2TVsSqUHG(l&9B$W6t/h%7\aXM%Cir\i2._%Ji.+39dN/_+3s_ '/?\rj?A/K;`!k87I1u`'0UB9f)!\@HhTMEN0F9&5L^,G6-tiJ%7AMW9bg+EP\hF2^W6Z~> endstream endobj 67 0 obj 607 endobj 68 0 obj << /Filter [ /ASCII85Decode /LZWDecode ] /Width 74 /Height 105 /ColorSpace 61 0 R /BitsPerComponent 8 /Length 69 0 R >> stream J2Q7]3$]7K#D>EP:q1$o*=mro@So+\<\5,H7Uo<*H3QMSO@Wn[3-9I,-^757:rs]c >p4gCk#2P%c>=\kbF8"sSDJYrT1u/%g'm7^7@@!2FG`a)R3.8akgR,-MNp]3af?/F KfZ_pP1T$-GWgr)!jPlWF=>D&[8aNalgpS,L!5`qF=>E.htEl"@43PN\Z)(abtOolp5TT'e7)&gj(J<$(F\[7T,bq1!Gh4 bqmTX9[u#FPAK&6c4_)t~> endstream endobj 69 0 obj 558 endobj 70 0 obj << /Filter [ /ASCII85Decode /LZWDecode ] /Width 74 /Height 105 /ColorSpace 61 0 R /BitsPerComponent 8 /Length 71 0 R >> stream J2Q7]3$]7K#D>EP:q1$o*=mro@So+\<\5,H7Uo;k$3i4*O@UU:3@'nb-\]WQ;Rp>D $S@`>+u:+4Wa@WR9]m'l][BG7Sj94fR7.lE/Yg\T:tenR#>L=OB2o8F&m[u,9'Q#9 oh(3NM9dX$]&\#TAZ\t7&a4qOfjpYo/!+OhR_a3&?#J7%S[R-5ZIJ"k.s7HVJ8*KS9PE`kN%="Tc_Aoh+fk'&t\ctIN)4XQLiVpoI(>.nOW?*DmsG$@,,f58"P DKfeXi0S^6MAH endstream endobj 71 0 obj 313 endobj xref 0 2 0000000000 65535 f 0000113811 00000 n 19 1 0000113913 00000 n 22 1 0000114018 00000 n 26 1 0000114123 00000 n 60 12 0000114228 00000 n 0000114513 00000 n 0000114566 00000 n 0000115149 00000 n 0000115170 00000 n 0000115851 00000 n 0000115872 00000 n 0000116636 00000 n 0000116657 00000 n 0000117372 00000 n 0000117393 00000 n 0000117863 00000 n trailer << /Size 72 /Info 60 0 R /Root 59 0 R /Prev 112422 /ID[<5cf32e45a1c844568ea61a5dea70ac1d>] >> startxref 117884 %%EOF